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 Implantation is a critical developmental milestone for early human embryogenesis and 
successful pregnancy. During implantation, the pluripotent epiblast gives rise to the squamous 
amnion and the columnar embryonic disc, which together enclose the amniotic cavity to form an 
asymmetric cystic structure called the amniotic sac. Amniogenesis - the development of amnion - 
marks the first differentiation of the epiblast during implantation; in parallel, the formation of the 
amniotic sac delineates the morphology of the human embryo and prepares it for subsequent 
gastrulation. Despite its fundamental and clinical importance, the development of the amnion and 
the amniotic sac in humans remains mysterious due to the scarcity and restricted availability of 
in vivo human embryo specimens and the lack of in vitro models.  
 In this dissertation, we report the first in vitro model for peri-implantation human 
amniogenesis and amniotic sac development, by culturing human pluripotent stem cells (hPSCs) 
in a bioengineered niche that mimics the physical microenvironment experienced by human 
embryos during implantation. Specifically, we find that hPSCs cultured in such implantation-like 
niche undergo self-organized development and form three dimensional (3D) structures in vitro 
that molecularly and morphologically resemble human amnion and human amniotic sac in vivo. 
We further show that implantation-like physical niche cues - a soft tissue bed and a 3D 
extracellular matrix (ECM) - are both necessary and sufficient for triggering the amniogenic 
development in an otherwise self-renewal-permissive biochemical context. We also demonstrate 
xv 
that the hPSC-derived amniotic sac embryoid can model human amniotic sac development 
beyond the peri-implantation stage with primitive streak-like development. Additionally, we 
unveil an endogenous BMP-SMAD signaling underlying peri-implantation human amniogenesis 
and amniotic sac patterning.  
 Furthermore, we demonstrate an integrative mechanotransduction that can induce 
amniogenesis of hPSCs by integrating multiple upstream signals including substrate rigidity, cell 
cluster size, and cell spreading. Enabled by such new knowledge, we have developed a novel 
micro-engineered array of hPSC-derived amnion-like tissues, as a potential high-throughput 
screening platform for regenerative medicine.   
 Together, findings in this dissertation provide innovative in vitro systems for investigating 
early human embryogenesis during implantation and early gastrulation, thereby helping advance 









 After fertilization, the human embryo embarks on a 40-week journey that gradually reveals 
the complexity and beauty of life (Figure 1-1). Starting from a fertilized egg, the human embryo 
first develops into a hollow structure called blastocyst during the first week of pregnancy. This 
pre-implantation embryo next undergoes implantation, gastrulation, and body folding in an 
orchestrated manner to establish the overall body plan of the human embryo by the end of the 
first month. Organogenesis, which initiates near the end of the first month, gives rise to a variety 
of organ rudiments that evolve into organ systems with a myriad of functions, constituting the 
sophisticated biological machinery for the development and intrauterine life of a human fetus. 
Together, these early developmental events lay the foundations that are indispensible for human 
embryo development.  
 Ever since the bewilderment manifested by ancient philosophers, "the development of the 
human" has been a question that not only stimulates philosophical thoughts on human nature but 
 
Figure 1-1 Timeline of human embryonic development. 
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also drives the advancement of modern science and medicine. Despite of such importance, our 
understanding of human development, especially the aforementioned early stages, is still limited, 
largely due to the ethical controversies surrounding in vivo experimentation and the lack of 
technologies for in vitro studies. The goal of this dissertation is therefore to fill such a gap in 
knowledge and technology, by taking advantage of the recent rise of human pluripotent stem cell 
engineering to develop in vitro methods for studying human development during implantation - a 
critical developmental milestone that ensues during the second week of pregnancy. 
 In this chapter, I will briefly summarize the background and the outline of this dissertation. 
   
1.1 Human Embryogenesis in the First Two Weeks of Pregnancy  
 Herein, I present a concise summary of our current understanding of early human 
development1 during the first two weeks of pregnancy (Figure 1-2), with a focus on the peri-
/post-implantation development of the embryo during the second week, when it forms the 
Figure 1-2 Schematic summarizing the development of human embryo during the first two 
weeks of pregnancy. The epiblast, amnion, and the amniotic cavity constitute the amniotic sac. 
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amniotic sac - a key developmental structure that delineates the rudimentary morphology of the 
human embryo enveloped by the amnion. 
1.1.1 Pre-implantation Development of the Human Embryo 
 After the union of egg and sperm upon fertilization/conception in the oviduct, the zygote 
travels down the oviduct and undergoes its fist cleavage (Figure 1-2). With a series of cleavages 
that follow, the embryo develops into a solid cluster of multiple cells (Figure 1-2). Cells in the 
embryo at this stage are called blastomeres and each blastomere has the so-called "totipotency" - 
the capability of differentiating and becoming any cell type in the human body. Upon further 
development, the morula differentiates into two distinct populations of cells with different 
localization and destiny. Specifically, through a process called compaction, some cells in the 
morula are excluded from the surface and internalized into the embryo to form the inner cell 
mass (ICM). In the meantime, the outer cells of the morula compact into a thin epithelial layer 
called the trophectoderm (TE), which contains cells named trophoblast and surrounds the inner 
cell mass with a cavity - the blastocoele (Figure 1-2). During further development, the ICM will 
give rise to the embryo proper and embryo-associated extraembryonic tissues such as the amnion 
and the yolk sac; in contrast, the TE will develop into part of the placenta and some other 
extraembryonic tissues. At this stage, cells residing in the ICM, but not TE, have the 
characteristic of "pluripotency" - the capability of generating all human cell types including the 
three germ layers that constitute the embryo proper. By days post fertilization (d.p.f.) 5 - 6, the 
embryo develops into a hollow fluid-filled structure called a blastocyst and enters the uterine 
cavity, ready for the next step - implantation (Figure 1-2). More extensive summary of human 
pre-implantation embryo development can be found in a recent review by others2. 
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1.1.2 Peri- and Post-implantation Development of the Human Embryo 
 At d.p.f. 5 - 6, shortly before the human embryo (blastocyst) attaches to the endometrial 
lining of the uterine wall and begins its invasion into the maternal tissue (Figure 1-2) - a process 
named implantation, the embryo initiates a transformation via sorting the ICM into two distinct 
cell groups: the epiblast and the hypoblast (or primitive endoderm). Hypoblast - a differentiated 
cell type originating from ICM and lining one side of the ICM and later epiblast - will give rise 
to theprimary and secondary yolk sac. The epiblast, which retains the pluripotency from the ICM, 
will continue to generate the embryo proper and an important extraembryonic tissue that 
envelops the embryo till birth - the amnion. Together, the amnion and the epiblast enclose a 
fluid-filled cavity called the amniotic cavity, and thereby form an asymmetrically patterned sac-
like structure called the amniotic sac. The development of amnion and amniotic sac is of 
particular importance and represents the focus of this dissertation because it generates the basic 
morphology of a human embryo, which is the indispensable foundation for any later 
development of the embryo.      
 The development of the human embryo during implantation, commonly referred to as peri-
implantation or post-implantation development, is understood based on histological sections of 
 
Figure 1-3 Human amniotic sac development in vivo. Carnegie stage (CS) 5a-13, 5a-24, 5b3, 
and 5c5 human embryos at d.p.f. 7, 8, 9, and 12, respectively. A.C., pro-amniotic cavity; Epi., 
epiblast; Am., amnion. Sections are obtained from the Virtual Human Embryo project. 
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historically acquired human embryo samples accumulated in collections of human embryos, such 
as the Carnegie collection. As shown in Figure 1-3, sections obtained from the Carnegie 
collection demonstrate the histological changes during human amniotic sac development. 
Specifically, at d.p.f. 7 - about 1 day after implantation initiates - the embryo invades into the 
uterine wall and the cluster of epiblast cells undergoes polarization and forms a distinct cavity - 
the pro-amniotic cavity. Other than the establishment of epiblast polarity, there is no distinct sign 
of differentiation within the epiblast at this point. Interestingly, at d.p.f. 8, the columnar epiblast 
cells appear to align only along one side of the cavity, sitting next to the hypoblast layer; while 
seemingly flattened cell(s) enclose the cavity on the other side. The appearance of such flattened 
cells with a squamous morphology implies the differentiation towards presumptive amniotic 
cells (amnioblasts) from the epiblast in the embryo. Further development between d.p.f. 9 and 12 
clearly demonstrates the expansion of the squamous tissue on one side of the amniotic cavity 
with a paralleled expansion of columnar epiblast on the other side. Together, they organize into 
an asymmetrically patterned amniotic sac, whose amniotic pole nestles beside the developing 
trophoblast invading into the uterine wall while the epiblast pole sits next to the developing 
hypoblast. Such histogenesis of amnion and morphogenesis of amniotic sac is also observed in 
non-human primates, such as cynomolgus monkey and rhesus monkey6-8.  
 
1.2 Current Understanding of Peri-implantation Human Embryogenesis is Limited 
 In the past decade, rapid development of "omics" sciences and the availability of pre-
implantation human embryos for research purposes (via cryopreserved samples from in vitro 
fertilization clinics) have significantly advanced our understanding of pre-implantation human 
embryo development9-13. In contrast, our understanding of peri-implantation human 
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embryogenesis remains limited, due to the inaccessibility to peri-implantation human embryo 
samples. So far, knowledge about peri-implantation human embryogenesis is largely drawn from 
interpretations of images of sectioned human and primate embryos that were deposited in 
embryo collections more than 50 years ago. Despite recent excitement in developing in vitro 
systems for studying early human embryogenesis14-17, the induction of two key peri-implantation 
developmental structures - the amnion and the amniotic sac - in humans remains mysterious to 
date. Here, a brief summary is provided to highlight the gap in our current knowledge about peri-
implantation human amniogenesis and amniotic sac development.  
1.2.1 Different Hypotheses Suggested for Human and Non-human Primate Amniogenesis 
 At the commencement of implantation, the epiblast undergoes prominent cellular 
reorganization. Specifically, it transforms from an irregularly packed cell aggregate to a spherical 
cell cluster showing evidence of cell polarity, with the basal surface facing the basal lamina 
(which is deposited at the epiblast/hypoblast interface as well as the epiblast/trophoblast interface) 
and the apical surface oriented towards the interior (Figure 1-4). The epiblast cluster next 
undergoes lumenogenesis and form a cavity inside the cluster (Figure 1-4). Although it has been 
commonly accepted that such epiblast "cyst" is the precursor that further gives rise to the amnion 
and the amniotic sac, it is still under debate that how the subsequent induction and 
morphogenesis of amnion occurs in peri-implantation human embryos18 (Figure 1-4).  
 For example, in an early study published in 1975, Luckett conducted a histological analysis 
of archived images of sectioned human and monkey embryos6. In this study, Luckett proposed 
the hypothesis that the amniogenesis in primates initiates after a transient opening of the 
epiblastic cavity (cavity within the epiblast cyst) to the trophoblast, forming an epiblastic-
trophoblast cavity (Figure 1-4); upon further development, the proliferation, differentiation, and 
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migration of epiblast cells at the margins of the epiblast disc results in the up-folding of the 
epiblast layer and generates precursors of amniotic cells, which eventually enclose a permanent 
cavity ("the amniotic cavity") with the roof made of squamous cells destined to become the 
amnion. This hypothesis has been taken as a textbook dogma in human embryology1. 
 However, another study by Enders et al. in 1986 reported that they did not find signs of 
transiently opened epiblastic cavity after analyzing peri-implantation rhesus monkey embryos, 
thereby challenging the Luckett hypothesis. Instead, their findings implied a possible alternative 
route for primate amniogenesis, wherein the epiblast cells that face the trophoblast undergo a 
continuous "thinning" process and eventually become the squamous amniotic epithelium (Figure 
1-4), which does not involve a transiently opened epiblastic cavity. This hypothesis is also 
consistent with recent findings by Sasaki et al. in post-implantation cynomolgus monkey 
embryos19. These different conclusions and hypotheses about closely related primate species 
obscure our understanding of the development of human amnion and amniotic sac. 
 
 
Figure 1-4 Schematic illustrating two different hypotheses for the amniogenesis in 
human/primates. The process through which the amnion emerges remains mysterious to date. 
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 1.2.2 Interspecies Differences in Amniogenesis Limit the Relevance of Common Animal Models 
 For centuries, scientists have utilized various kinds of model organisms to study the 
fundamental principles underlying the development of the human embryo. Although the use of 
animal models has generated a large amount of fruitful results and significantly advanced our 
understanding of the fundamentals of development, it might fall short to serve for the study of 
human amnion development due to non-negligible interspecies differences. Specifically, in 
humans as well as non-human primates such as cynomolgus monkeys and rhesus monkeys, the 
amnion is the first tissue to differentiate from the pluripotent epiblast. Amniogenesis in primates 
occurs along with implantation and precedes the initiation of primitive streak development and 
gastrulation6,18,19. In drastic contrast, in mouse and chick, which are commonly used animal 
models in developmental biology, the development of amnion occurs after the initiation of 
primitive streak and takes place during the gastrulation18,20,21. Such distinct differences in the 
timing of amniogenesis might reflect different, species-specific strategies for cell fate allocation 
and embryonic patterning, thereby limiting the relevance of common animal models in the study 
of human amnion development. 
  
 
Figure 1-5 Interspecies differences in the timing of amniogenesis between human/primates 
and other commonly used non-primate animal models. 
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 1.2.3 In vitro Cultured Human Embryos Lack Definitive Amnion Development and Amnion-
Epiblast Patterning 
 In order to overcome the inaccessibility of peri-implantation human embryo samples for 
investigating human developmental biology during implantation, two research groups recently 
took advantage of discarded pre-implantation human blastocysts from in vitro fertilization clinics 
and cultured them in vitro to induce further development that recapitulates implantation (Figure 
1-6). In the study by Deglincerti et al., the authors cultured human embryos in vitro to develop 
and form two primary cavities: the amniotic cavity and the yolk sac, which are hallmarks of per-
implantation human embryos16. Similarly, another study by Shahbazi et al. also cultured human 
embryos to generate an amniotic cavity and a prospective yolk sac17. Despite their success in 
culturing human embryos in vitro to undergo implantation-like development for the first time, 
 
Figure 1-6 In vitro cultured human embryos. Recent work by Deglincerti et al.16 (a-c) and 
Shahbazi et al.17 (d-f) cultured human blastocysts in vitro. (a,d) Phase contrast images of the 
cultured human embryo at day 12 (a) and day 10 (b), respectively. (b,e) Schematic (b) and 
immunofluorescence analysis (e) of the cultured human embryo. Yellow boxes highlight the 
amniotic cavity. (c,f) Zoom-in views of the amniotic cavity boxed in b and e, respectively. 
Scale bars, 50 µm in a, d, e; 20 µm in c. Reproduced with permission. 
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neither study identified the development of definitive amniotic tissue, as reflected by the absence 
of OCT4- squamous amnion cells at the prospective amniotic pole (white arrows in Figure 1-
6c&f). Those cultured human embryos also lacked a clear amnion-epiblast patterning that 
resembles the human amniotic sac in vivo. Importantly, studies such as these still require the use 
of live human embryos and therefore are subjected to ethical controversies and additional 
limitations on the scale and efficiency of such studies.  
 
1.3 Human Pluripotent Stem Cells: a Promising Resource for Modeling Human 
Development in a Culture Dish 
 Compared with the valuable yet largely inaccessible/inefficient studies on human embryos 
both in vivo and ex vivo, the rise of human stem cells and stem cell engineering in recent years 
has provided us with a promising route to study human development in an efficient and scalable 
fashion in vitro22. In particular, human pluripotent stem cells (hPSCs), which share molecular 
similarity with human epiblast8,9,23 and have the potential to develop to many cell types in human 
embryos, are under the spotlight due to their capability of modeling human development and 
diseases in a culture dish24-28. However, at the time of initiation of this dissertation, it was still 
unexplored whether hPSCs have the potential to be applied to recapitulate peri-implantation 
human developmental events such as amniogenesis. The work herein explores such a potential 
and uses hPSCs as the cellular tool for developing in vitro models for peri-implantation human 
embryogenesis. Next, I present a brief summary of our current understanding of hPSCs and a 
concise review of recent applications of hPSCs to model human organogenesis in culture.  
1.3.1 Derivation of Human Pluripotent Stem Cells 
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 Historically, the term "human pluripotent stem cells" was originally used to unify the 
description of two kinds of cells: human embryonic stem cells (hESCs) and human induced 
pluripotent stem cells (hiPSCs), which are derived from different origins with different methods 
but share similar levels of pluripotency - the competence to differentiate into all three germ 
layers and their progenies (Figure 1-7). Specifically, hESCs are derived from the outgrowth of 
the human ICM after the ICM is isolated from the blastocyst and cultured in a dish29; while 
hiPSCs are derived from adult tissue cells, such as skin cells30 and blood cells31, via a process 
called reprogramming which can be achieved by forced expression of key transcription factors 
associated with pluripotency. Both hESCs and hiPSCs are regulated by the same set of 
pluripotency-associated transcriptional circuitry including key pluripotency factors NANOG, 
OCT4, and SOX232. Nevertheless, hESCs and hiPSCs are not identical. The extent to which 
hiPSCs are similar to their embryonic counterparts - hESCs - is often dependent on the protocol 
 
Figure 1-7 Derivation and application of hPSCs. Schematic showing the derivation of human 
embryonic stem cells (hESCs) and human induced pluripotent stem cells (hiPSCs), which 
together constitute hPSCs, as well as the typical application of hPSCs for generating human 
somatic cells via directed differentiation. 
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used for hiPSC derivation33,34. Therefore, it typically requires side-by-side comparisons to 
confirm the similarity of hiPSCs and hESCs in a context-dependent manner. It also calls for 
caution when attempting to extrapolate properties of hESCs to hiPSCs, or vice versa.  
 Since the discovery of hESCs and hiPSCs, researchers have been endeavoring to develop 
standardized culture systems for maintaining and expanding hPSCs, as well as a multitude of 
methods for directed differentiation of hPSCs towards somatic cells that are progenies of the 
three embryonic germ layers - ectoderm, mesoderm, and endoderm (Figure 1-7). Intriguingly, 
recent findings indicate that hPSCs are also competent for generating cells that resemble human 
primordial germ cells (hPGCs)35 as well as germ cells36, which, according to a recent report by 
Sasaki et al., originate from extraembryonic nascent amnion in cynomolgus monkey embryos19. 
Therefore, the above findings suggest that hPSCs might also be competent for generating cells of 
extraembryonic lineages, e.g., the amniotic lineage, as well.  
1.3.2 Pluripotency in Human Cells: a Developmental Spectrum 
 As mentioned in section 1.1, pluripotent cells exist at multiple early developmental stages in 
human embryos in vivo (Figure 1-8). For example, the ICM and the early epiblast in pre-
implantation embryos both exhibit pluripotency. The epiblast in post-implantation, pre-
gastrulation embryos also carries pluripotency. Given such a developmental spectrum of 
pluripotent states in vivo, the embryonic developmental stage to which hESCs and hiPSCs match 
in vitro has been a matter of intense debate for a long time.  
 Because it originates from the outgrowth of human ICM, hESCs were thought to reside in an 
ICM-like developmental stage, and so were hiPSCs because of their similarity to hESCs. 
However, hESCs and hiPSCs (referred to henceforth as conventional hPSCs in this section) were 
soon found to exhibit characteristics of the post-implantation epiblast instead of that of the ICM, 
13 
including a high level of DNA methylation12, prominent epithelial polarity, increased 
glycolysis37, and dependence on FGF2/ERK and TGFβ signaling for self-renewal38. A recent 
study by Nakamura et al. in post-implantation cynomolgus monkey embryos further indicates 
that conventional hPSCs are most similar to the post-implantation epiblast8.  
 In past years, researchers have also been actively exploring the possibility of generating 
hPSCs of alternative pluripotent states other than that of the post-implantation epiblast. For 
example, by expressing NANOG and KLF2 for a short time, Takashima et al. successfully reset 
conventional hPSCs to a "ground-state" that resembles the pre-implantation human blastocyst 
ICM39. These alternative hPSCs, typically called naive hPSCs or ground-state hPSCs, exhibit 
distinct molecular signatures compared with conventional hPSCs, e.g., largely reduced DNA 
methylation (a state called hypomethylation), activation of mitochondrial respiration, and self-
renewing maintenance in the absence of ERK signaling, which are hallmarks of the ICM in pre-
implantation human embryos. Recently, Guo et al. successfully derived native hPSCs directly 
 




from human ICM40, further confirming the existence of an alternative, human ICM-like 
pluripotent state in cultured human cells in vitro. 
 In another recent study by Wu et al., the authors identified an alternative epiblast-like 
pluripotent state in cultured hPSCs41. Specifically, by removing TGFβ1 from conventional hPSC 
culture medium and supplementing a small molecule inhibitor for WNT signaling, IWR1, they 
successfully reset conventional hPSCs to a different pluripotent state, which features more 
efficient generation of post-implantation interspecies chimaeric embryos and higher cloning 
efficiency when compared with conventional hPSCs. Because those alternative hPSCs show 
most efficient integration into the posterior region of post-implantation interspecies chimaeric 
embryos, they were named region-selective hPSCs (rs-hPSCs or human rsPSCs)41. These human 
rsPSCs were therefore also hypothesized to reside in a late, yet still pluripotent, epiblast-like 
developmental state.  
 Together, such a developmental spectrum of pluripotent states and their distinct in vitro 
counterparts in cultured hPSCs could provide us with a comprehensive set of resources for 
modeling diverse early human embryogenic events in vitro.  
1.3.3 3D Organotypic Culture of hPSCs for Modeling Human Organogenesis 
 The fate and organization of cells in the human body are tightly regulated in the three-
dimensional (3D) cell microenvironment through intricate interactions with neighboring cells, 
the surrounding extracellular matrix (ECM), and soluble biochemical cues42,43. Thus, to 
recapitulate in vivo-like cellular structures, properties, and organizations using hPSCs, it is 
critical to control and modulate the 3D cell microenvironment mimicking tissue- and organ-
specific niches24. By leveraging the self-organizing cytodifferentiation of hPSCs in properly 
designed tissue-mimicking microenvironments, biologists and bioengineers have developed a 
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range of 3D hPSC culture systems for modeling the development of various human organs in the 
last ten yesrs25,44. A brief summary of these hPSC-derived organ developmental models, 
commonly called the organoids, is provided here24.  
 The late developmental biologist Yoshiki Sasai and his colleagues have done pioneering 
work that utilizes hPSCs to model the development of organs of neuroectodermal lineage. Using 
serum-free culture of embryoid body-like aggregates (SFEB), Sasai and colleagues recapitulated 
3D optic cup morphogenesis using hESCs (Figure 1-9a)45. In another work from Sasai and 
colleagues, hESCs were induced toward neuroepithelial lineages and cortical tissues exhibiting 
distinct zones along the apical-basal axis (e.g., ventricular, early and late cortical plate, and 
Cajal-Retzius cell zones) were generated (Figure 1-9b)46. Recently, Mariani et al. extended the 
SFEB method to hiPSCs and generated human cortical organoids mimicking the developing 
human telencephalon47. In addition, via co-induction of hypothalamic neuroepithelium and oral 
ectoderm in a 3D culture system, Ozone et al. generated anterior pituitary organoids from 
hESCs48. In another exciting study, Lancaster et al. successfully applied 3D hPSC culture to 
generate cerebral organoids with distinct brain regions (Figure 1-9c)49. Intriguingly, early 
corticogenesis and subsequent patterning of forebrain, midbrain, and hindbrain regions were 
observed in cerebral organoids. Importantly, using hiPSCs derived from patients of microcephaly, 
Lancaster et al. successfully modeled critical pathological phenotypes of microcephaly in 
cerebral organoids.  
 3D organotypic culture methods have also been successfully applied to generate organoids 
with mesodermal and endodermal origins. By inducing hESCs toward the primitive streak-
intermediate mesodermal lineage, Takasato et al. generated self-organized human kidney 
organoids that exhibited ureteric buds, metanephric mesenchyme, and nephron formation (Figure 
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1-9d)50. Recently, Takasato et al. reported an improved method for inducing kidney organoids 
that contain nephrons associated with a collecting duct network surrounded by renal interstitium 
and endothelial cells, which shows high similarity to the first trimester human kidney51. In 
another work from Kusuma et al., an hPSC-derived microvascular network was demonstrated 
through co-differentiation with vascular endothelial cells and pericytes and subsequent 
encapsulation in HA-based hydrogel (Figure 1-9e)52. A relevant work to engineer functional 
human blood vessels in 3D culture using hiPSC-derived endothelial cells and mesenchymal 
precursor cells was recently reported by Samuel et al 53.  
 Following endodermal commitment, Spence et al. successfully generated human intestinal 
organoids (HIOs) from hPSCs using a Matrigel-based 3D culture system (Figure 1-9f)54. 
Through temporally controlling growth factors to dictate sequential definitive endoderm, 
posterior endoderm, and hindgut specification and morphogenesis, Spence et al. created in vitro 
intestines containing villus-like structures and crypt-like proliferative zones. Such HIOs was 
further utilized for studying the roles of WNT3a and FGF4 in intestine development and 
NEUROG3 (a pro-endocrine transcription factor) in human enteroendocrine cell development 
and disease. More recently, Watson et al. successfully implanted human intestinal organoids 
generated from hPSCs in vitro into mice, and observed significant maturation of HIO to form 
human adult-like small intestinal tissue with vasculature integration with the mouse host. This 
work supports the feasibility of using human intestinal organoids to study human small intestine 
maturation and relevant adult intestinal diseases55. Based on the hindgut organoid model, 
McCracken et al. developed a method to generate posterior foregut organoid that eventually 
gives rise to human gastric organoid (hGO) by manipulating the BMP, retinoic acid, and EGF 
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signaling pathways (Figure 1-9g). This hGO model was used to study the fundamentals of 
human stomach development as well as gastric pathogenesis caused by H. pylori infection56.  
 In a separate study, Takebe et al. recreated human liver buds in vitro by leveraging 3D self-
organization of hiPSC-derive immature hepatic cells and human endothelial and mesenchymal 
stem cells under coculture (Figure 1-9h)57. Interestingly, such in vitro engineered human liver 
buds matured and functioned like adult human liver after transplantation and could even rescue 
drug-induce lethal liver failure mouse models. By differentiating hPSCs to NKX6.1+/PDX1+ 
pancreatic exocrine progenitor cells and culturing those progenitor cells in a 3D environment, 
Huang et al. generated pancreatic organoids containing ductal and acinar structures both in vitro 
and after transplantation (Figure 1-9i)58. Using progenitors with mutant KRAS and TP53, the 
pancreatic organoid was used to model pancreatic ductal adenocarcinoma for drug screening. 
Recently, Dye et al. induced hPSCs into ventral anterior foregut spheroids, which were then 
expanded to form human lung organoids (HLO)59,60. HLO contains epithelial and mesenchymal 
compartments and exhibits airway-like structures resembling human lung when grown both in 
vitro and after transplantation.   
 Together, recent developments of various human organoids using 3D biomaterial-based 
culture methods highlight the great potential of hPSCs in conjunction with conductive 3D culture 
environment for fundamental organ development studies, critical for identifying therapeutic 
targets for treating complex developmental or degenerative diseases. However, it is noteworthy 
that despite the extensive and successful utilization of hPSCs for modeling organogenesis, which 
is a post-gastrulation developmental period, it remains undetermined whether hPSCs can be 
applied to model pre-gastrulation, peri-implantation human embryogenic events such as 










1.4 Dissertation Outline 
 Given: (1) the intense interest and significance in advancing our understanding of early 
human embryogenesis; (2) the current gap in knowledge and technology for understanding peri-
implantation human development, especially the development of amnion and amniotic sac; (3) 
successful precedents utilizing hPSCs to model post-gastrulation organogenesis by providing 
rationally designed, biomimetic 3D culture environments, and (4) the similarity between hPSCs 
and the peri-/post-implantation epiblast that gives rise to amniotic cells during the second week 
of pregnancy, the goal of this dissertation is to leverage 3D hPSC bioengineering to develop the 
first in vitro models for studying peri-implantation human amniogenesis and amniotic sac 
development. Specifically, I will first develop a biomimetic implantation-like biophysical niche 
for inducing amniogenesis from hPSCs in Chapter II. In Chapter III, this implantation-like niche 
will be further applied to generate an asymmetric cystic structure resembling human amniotic sac 
at implantation and early gastrulation. Chapter IV will summarize a pilot study that aims at 
translating the hPSC amniogenesis system to a micro-array platform that is potentially useful for 
high-throughput screening for reproductive medicine in the future. Finally, Chapter V will 









Self-organized Amniogenesis by Human Pluripotent Stem Cells in a 
Biomimetic Implantation-like Biophysical Niche 
2.1 Introduction 
 Development of amnion, which occurs between d.p.f. 6 and 12, is the first - although poorly 
studied - differentiation event that happens in the human epiblast and is indispensible for further 
developmental events such as gastrulation6,18. Abnormal amnion development can evolve into 
critical pregnancy complications, such as oligohydramnios or amniotic band syndrome. Amnion 
also has anti-inflammatory and pro-regenerative functions that have been leveraged in clinics for 
facilitating wound healing62. Despite its fundamental and clinical significance, amnion 
development in the human remains little understood, due to the inaccessibility to 6-12 d.p.f. 
human embryos and the drastic difference in amnion development between human and other 
common animal models. Recently, there has been significant progress in developing in vitro 
culture systems, including in vitro cultured human embryos as published by Deglincerti et al.16 
and Shahbazi et al.17 to expand our knowledge of early human development. While such studies 
using live human embryos are valuable, they are inefficient, non-scalable, and ethically 
controversial. Thus, human-specific amnion development remains mysterious and poorly 
approachable.  
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 In past years, hPSCs have been successfully utilized for modeling post-gastrulation human 
embryonic development14,49. However, the applicability of hPSCs for modeling peri-implantation, 
pre-gastrulation developmental events, such as amniogenesis, remains undetermined. Inspired by 
the recently implicated cell biological and transcriptomic similarities between hPSCs and peri-
/post-implantation epiblast8,17,23,63, which gives rise to nascent amnion, the goal of this chapter is 
to adapt a biomimicry approach to engineer a biomaterial-based in vitro hPSC culture system for 
efficient generation of early human amniotic tissue.† 
 
2.2 Biomimetic Implantation-like Biophysical Niche: Rationale and Design 
 Because the in vivo milieu of the embryo implantation site is complex and has not yet been 
fully elucidated, it is not practical at this point to fully recapitulate all aspects of the peri-
implantation microenvironment to reconstruct a biomimetic implantation-like amniogenic niche 
in vitro. Instead, here I chose to concentrate on two central concepts that address key features of 
the peri-implantation environment. 
 Firstly, during the implantation of human embryo, amniotic differentiation initiates in 
parallel with self-renewing expansion of the pluripotent epiblast. Therefore, it is hypothesized 
here that a biochemical context permissive for maintaining the pluripotent epiblast might also be 
permissive for initial amnion development. Such a biochemical context can be mimicked by 
conditions that have been used extensively in the feeder-free culture system for maintaining 
hPSCs: the mTeSR1 medium and a basement membrane matrix (herein GeltrexTM), of which the 
                                                 
† The results presented in this chapter are adapted from my recent publication: Shao et al., Nature Materials, in press, 
DOI: 10.1038/NMAT4829. 
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latter is also the first type of extracellular matrix formed surrounding the epiblast in primate 
embryos at implantation7.  
 Secondly, the conventional cell culture system for hPSCs utilizes a two dimensional (2D) 
setting in which cells are plated on a stiff plastic/glass substrate thinly coated by basement 
membrane matrix proteins. In contrast, the in vivo peri-implantation environment has notably 
different physical properties (Figure 2-1a). For example, implantation occurs as the embryo 
nestles against a bed of maternal tissue and trophoblast cells. This environment should be 
mechanically more similar to a soft hydrogel than to a rigid piece of plastic. In addition, the 
hypoblast and underlying basement membrane matrix surround the epiblast with a 3D 
extracellular matrix (ECM) environment in vivo. To mimic these two physical features of the 
peri-implantation niche, a thick soft gel bed made of basement membrane matrix (GeltrexTM) and 
an ECM overlay (also containing basement membrane matrix protein) are incorporated in the 
implantation-like culture system in vitro (Figure 2-1b). 
Figure 2-1 Rationale of the biomimetic implantation-like niche. (a) Development of 
amnion/amnioblasts from epiblasts in a peri-implantation human embryo18. Amniogenesis in 
vivo occurs in a biophysical niche featuring a soft tissue bed (maternal tissue and invading 
trophoblasts) and a 3D ECM environment provided by the overlying primitive 
endoderm/hypoblasts. (b) Schematic of the implantation-like "Gel-3D" culture system, which 
contains a thick, soft gel bed and a 3D ECM overlay. 
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 In this culture system, H9 human embryonic stem cells (hESCs) were plated as single cells 
at 30,000 cells cm-2 onto a thick and soft basement membrane matrix gel bed (GeltrexTM, with 
thickness ≥ 100 µm, bulk Young's modulus ~900 Pa64, coated on glass coverslip) in mTeSR1 
medium supplemented with Y27632, a ROCK inhibitor that prevents dissociation-induced 
apoptosis65 (Figure 2-2). At 24 h (day 1), Y27632 was removed and 4% (v : v) GeltrexTM was 
added in mTeSR1 to establish a 3D implantation-like niche (referred to henceforth as "Gel-3D" 
condition). To assess the effect of ECM dimensionality and matrix rigidity, respectively, several 
modifications of this Gel-3D condition were also tested (Figure 2-2). First, the GeltrexTM 
supplement was excluded from the medium, with the gel bed retained (referred to henceforth as 
"Gel-2D" condition). Second, the soft gel bed was replaced with a 1% GeltrexTM-coated glass 
coverslip (referred to henceforth as "Glass-3D" condition). Finally, a standard 2D culture, using 
a 1% GeltrexTM-coated glass coverslip (referred to henceforth as "Glass-2D" condition), was 
examined as a control that maintains hPSC self-renewal. Culture medium was replenished daily. 
Analyses were performed for all conditions at day 5 unless otherwise noted (Figure 2-2). 
 
 
Figure 2-2 Schematic showing the hPSC amniogenesis assay. 
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2.3 Materials and Methods 
2.3.1 Fabrication of Basement Membrane Matrix Gel Beds 
 Fabrication protocol for the GeltrexTM gel bed was based on a "sandwich" setup previously 
developed for generating polyacrylamide gel substrates66-68. To prepare a substrate that the gel 
bed could attach to, a 22 × 22 mm2 glass coverslip was first treated with air plasma (Harrick 
Plasma) for 2 min before coated with 0.1 mg ml-1 poly-(L-lysine) (PLL) solution (Sigma-Aldrich) 
for 30 min, and 1% glutaraldehyde solution (Electron Microscopy Sciences) for another 30 min. 
To prepare a substrate that could "sandwich" and release the gel bed, a pre-cleaned glass slide 
was treated with air plasma for 2 min before coated with 0.1 mg ml-1 poly-(L-lysine)-graft-poly-
(ethylene glycol) (PLL-g-PEG; SuSoS) solution for 1 h. To obtain gel beds with nominal 
thickness of 20, 60, and 100 µm, undiluted GeltrexTM (10, 30 and 50 µl, respectively) was 
sandwiched between the pre-treated glass coverslip and glass slide on ice before incubated at 
37°C for 30 min for gelation. The gel bed, which was attached to the glass coverslip, was then 
removed from the glass slide and submerged in DMEM/F12 medium (Thermo Fisher Scientific) 
and incubated at 37°C overnight before plating cells.  
 To prepare gel beds with a nominal thickness larger than 100 µm, spacers with the desired 
thickness were placed between the glass coverslip and the glass slide when preparing the gel bed 
sandwich. Specifically, spacers were made of polydimethylsiloxane (PDMS; Dow Corning) 
films. The film was made by spin-coating liquid phase PDMS (mixed at 10:1 of base:curing 
agent ratio) onto a petri-dish at 500 rpm for 40 s (for generating 150 µm thick film) and cured at 
70°C for at least 24 h before use. A previously published "PDMS film thickness - spin coating 
parameter" chart69 can be referred to when preparing PDMS films of desired thicknesses. 
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2.3.2 Fabrication of Elastomeric Artificial Matrices 
 The elastomeric artificial matrix consisted of a regular PDMS micropost array generated 
using a microfabrication protocol previously published70. To functionalize inert PDMS surfaces 
for cell attachment, the PDMS micropost array was treated with air plasma for 2 min and coated 
with 1% GeltrexTM solution for 2 h. The GeltrexTM solution was aspirated, and the PDMS 
micropost array was rinsed with DMEM/F12 before plating hPSCs.  
 Finite element analysis was performed to determine the nominal spring constant, K, of the 
PDMS micropost under lateral force applied at the micropost top as previously described71. The 
nominal spring constant K was converted to an "effective in-plane substrate rigidity Eeff", by Eeff 
= 9K / 2D72, where D = 1.83 µm was the micropost diameter. 
2.3.3 3D Amniogenesis Assay 
 Three different kinds of substrates were used in this study: glass coverslip coated with 1% 
GeltrexTM solution for 1 h at room temperature, GeltrexTM beds of different nominal thicknesses 
(as described below), and artificial matrices of different effective rigidities (as described below). 
Cultured hPSC colonies were first incubated with Accutase (Sigma-Aldrich) at 37°C for 10 min 
before triturated and suspended in PBS as single cells. hPSCs were then centrifuged and the cell 
pellet was resuspended in mTeSR1 containing 10 µM Y27632 (Tocris). hPSCs were plated as 
single cells at 30,000 cells cm-2 onto the indicated substrate. After 24 h (on day 1), culture 
medium was changed to fresh mTeSR1 without Y27632. For 3D culture conditions, 4% (v : v) 
GeltrexTM was supplemented in mTeSR1 medium on day 1, as previously described63. Thereafter, 
mTeSR1 medium was replenished daily, and 4% (v : v) GeltrexTM was supplemented daily for all 
3D culture conditions. 
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2.3.4 BMP Inhibition Assay 
 500 nM BMP receptor ALK2/3 inhibitor LDN193189 (LDN; STEMCELL Technologies) 
was added to the culture medium, either on day 2 only or on both days 2 and 3. DMSO (Sigma-
Aldrich) was added to control groups on both days 2 and 3. In experimental groups treated with 
LDN on day 2 only, DMSO was supplemented on day 3. No LDN or DMSO was added to the 
culture medium on days other than those specified above. 
2.3.5 Derivation of Primitive Streak Cells 
 Primitive streak (PS) cells were derived from hPSCs according to a previously published 
protocol73. In brief, hPSCs (H9 line) were dissociated and plated as single cells at 20,000 cells 
cm-2 onto glass coverslips coated with 1% GetlrexTM solution in mTeSR1 medium containing 10 
µM Y27632. After 24 h (on day 1), culture medium was replaced by fresh mTeSR1 without 
Y27632. On day 2, mTeSR1 was replaced by PS-differentiation medium containing Essential 
6TM medium (Thermo Fisher Scientific), 20 ng ml-1 FGF2 (Peprotech), and 8 µM CHIR99021 
(Tocris). PS cell differentiation was induced for 48 h before performing downstream assays. 
 
2.4 Results and Discussion 
2.4.1 hPSCs Self-organize into Squamous Cystic Tissue with Amnion-like Epithelial Morphology 
in the Implantation-like Niche 
 In the Glass-2D condition, as expected, apico-basally polarized hESC colonies were 
observed at day 5. Strikingly, in Gel-2D, Glass-3D, and Gel-3D conditions, hESCs formed 3D 
cysts with EZRIN+ lumenal apical surfaces facing inward (Figure 2-3a), reflecting the intrinsic 
lumenogenic property of hESCs17,63. In both Gel-2D and Glass-3D conditions, > 90% of lumenal 
cysts are made of tall, columnar E-CADHERIN+ (ECAD+) epithelial cells with apico-basally  
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Figure 2-3 hPSCs self-organize to form squamous epithelial cystic tissues in the 
implantation-like niche. (a) Cartoons showing hPSC morphogenesis under different culture 
conditions (top). Confocal micrographs showing the X-Y (middle) and X-Z (bottom) sections of 
the hPSC monolayer and cysts formed in indicated conditions at day 5. EZRIN (green) 
demarcates apical surfaces. HOECHST (blue) counterstains nuclei. (b) Confocal micrographs 
showing staining of E-CADHERIN (ECAD, green; top), wheat germ agglutinin (WGA, red; 
bottom), and HOECHST (blue, nucleus) in hPSCs cultured under indicated conditions. 
Squamous cells exhibit basal ECAD+ protrusions, highlighted by white arrowheads. (c) Box 
charts showing normalized nucleus dimension (left) and epithelium thickness (right) for hPSC 
cysts in indicated conditions (box: 25% - 75%, bar-in-box: median, and whiskers: 1% and 
99%). Cartoons show columnar versus flat, squamous cyst morphologies and the apico-basal 
(api-bas) and lateral (lat) directions. ncell = 179, 254, and 243, and ncyst = 11, 11, and 23, for 
Gel-2D, Glass-3D, and Gel-3D, respectively. Quantitation was performed on n = 4 
independent experiments. P-values were calculated using unpaired, two-sided Student's t-test. 
***: P < 0.001. (d) Stacked bar plots showing percentages of hPSC colonies or hPSC-derived 
epithelial cysts with different morphologies under different culture conditions as indicated. ncyst 
(ncolony) = 100, 502, 469, and 694 for Glass-2D, Gel-2D, Glass-3D, and Gel-3D conditions, 
respectively. Data represent the mean ± s.e.m with n = 3 biological replicates from n = 2 
independent experiments. Same observation has been successfully repeated in total n = 16 
independent experiments. Scale bars in a&b, 50 µm.  
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elongated nuclei and thick epithelium (Figure 2-3b,c,d). In distinct contrast, > 90% of cysts 
formed in Gel-3D show a squamous epithelial morphology featuring flattened, laterally 
elongated cell nuclei and reduced epithelium thickness, as well as unique ECAD+ cellular 
protrusions extending from basal surfaces (Figure 2-3b,c,d). Intriguingly, this spontaneously 
developed squamous epithelial cystic tissue is morphologically reminiscent of the developing 
amnion in peri-implantation human embryos17,18. 
2.4.2 The Squamous Cystic Tissue is Spontaneously Differentiated in a Self-renewal Permissive 
Biochemical Context 
 Notably, all 3D columnar epithelial cysts that formed in both Gel-2D and Glass-3D 
conditions express pluripotency markers NANOG, OCT4, and SOX232, consistent with the well-
known association between columnar epithelial morphology and pluripotent epiblasts in vivo6,8,16 
 
Figure 2-4 hPSC-derived squamous cystic tissues undergo spontaneous differentiation and 
lose pluripotency markers. (a) Confocal micrographs showing NANOG (top), OCT4 (middle), 
and SOX2 (bottom) immunostaining in hPSCs cultured under indicated conditions. WGA co-
staining shows cell morphology. n = 9 independent experiments. Scale bar, 50 µm. (b) 
Western blot showing protein levels of NANOG, OCT4, SOX2, ECAD, and GAPDH in 
hPSCs cultured under indicated conditions. n = 3 independent experiments. 
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(Figure 2-4a). However, in the squamous cysts that formed in Gel-3D condition, expression of 
NANOG, OCT4, and SOX2 protein is lost, suggesting that they are composed of a differentiated 
cell type (Figure 2-4b). Interestingly, qRT-PCR analysis shows reduction in mRNA expression 
for NANOG and SOX2, but not OCT4 (also known as POU5F1), in the Gel-3D condition (Figure 
2-5a), suggesting a blunted transcriptional regulation of OCT4. Despite loss  
 of pluripotency markers, the squamous cyst maintains an epithelial phenotype, retaining 
expression of ECAD/CDH1 and CLDN674 (Figure 2-4b, 2-5b). Interestingly, such loss of 
pluripotency in parallel with squamous epithelial morphogenesis is also recently observed by  
 
Figure 2-5 Squamous epithelial cysts derived from hPSCs show blunted transcriptional 
suppression of pluripotency genes while maintaining epithelial features. qRT-PCR analysis of 
pluripotency genes NANOG, OCT4, and SOX2 (a), as well as epithelial markers CDH1 and 
CLDN6 (b), for hPSCs cultured in indicated conditions. Data were normalized against 
GAPDH and plotted as the mean ± s.e.m, with n = 4 - 5 biological replicates indicated by 
individual dots under each condition. n = 2 independent experiments. P-values were calculated 
using unpaired, two-sided Student's t-test. **: P < 0.01. 
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Figure 2-6 Morphogenic cytodifferentiation of hPSCs over time in the implantation-like Gel-
3D niche. (a) Confocal micrographs taken at different days (as indicated), showing 
immunostaining of ECAD (green) and counterstaining by HOECHST (blue) to examine 
morphological evolution of hPSCs cultured in the implantation-like Gel-3D niche. Magnified 
views of individual cysts (marked by white arrowheads) at different time points reveal a 
morphological transition from columnar to intermediate, to squamous cysts (a1-a6). Some 
hPSC clusters (marked by magenta arrows) did not form recognizable open lumens at day 2 or 
day 3. Such clusters were excluded from the quantification of time-dependent cyst 
morphological change in b. (b) Stacked bar plot showing percentages of hPSC-derived 
epithelial cysts with different morphologies in the implantation-like Gel-3D niche at days 2, 3, 
4, and 5. Data represent the mean ± s.e.m with ncyst = 424 (day 2), 534 (day 3), 652 (day 4), 
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 Sasaki et al. in the development of nascent amnion in monkey embryos19.  
 Furthermore, the dynamics of squamous epithelial cyst development in Gel-3D condition 
was also examined (Figure 2-6). On day 2, majority of epithelial cysts were lumenal and 
columnar (Figure 2-6a,b). Such columnar cyst morphology was transient, however, and by day 4, 
most cysts had become flat and squamous (Figure 2-6a,b). During morphological evolution of 
lumenal epithelial cysts, NANOG and OCT4 were gradually lost, with most dramatic changed 
observed between day 2 and day 4 (Figure 2-6c). These findings suggest concurrent squamous 
epithelial morphogenesis and spontaneous cytodifferentiation.  
 Spontaneous self-organized development of squamous epithelial cysts was also observed in 
two additional hESC lines (UM63-1 and H7) and an hiPSC line (1196a) cultured in Gel-3D, but 
not under Glass-2D, Gel-2D, or Glass-3D conditions (Figure 2-7). Thus, uniquely among all 
conditions examined, the implantation-like Gel-3D biophysical niche is both necessary and 
sufficient for efficiently inducing spontaneous self-organization and differentiation of hPSCs to a 
cystic epithelial tissue with amnion-like squamous morphology, under biochemical conditions 






and 542 (day5). n = 3 biological replicates for each condition. (c) Confocal micrographs 
showing co-staining of NANOG (red) and OCT4 (green) for hPSCs cultured in the 
implantation-like Gel-3D niche at different days as indicated. HOECHST (blue) counterstains 




Figure 2-7 The implantation-like Gel-3D niche induces spontaneous, self-organized 
development of squamous epithelial cysts from multiple hPSC lines. Confocal micrographs 
showing immunostaining of NANOG (red; top), OCT4 (green; middle), and SOX2 (red; 
bottom), with WGA (purple; top and middle), and ECAD (green; bottom), in the UM63-1 
hESC line (a), H7 hESC line (c), and 1196a hiPSC line (e) cultured under indicated 
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2.4.3 Development of the Squamous Cyst is Sensitive to the Mechanical Property of the Niche 
 Since the thickness of a soft gel bed coated on glass coverslip is negatively correlated with 
the apparent substrate rigidity75, above results suggest that the development of the squamous  
conditions. Scale bars, 50 µm. Western blot showing expression levels of NANOG, OCT4, 
SOX2, ECAD, and GAPDH in the UM63-1 hESC (b), H7 hESC (d), and 1196a hiPSC (f) 
cultured under indicated conditions. Immunofluorescence staining and Western blotting for 
each cell line was conducted for n = 2 independent experiments.  
 
 
Figure 2-8 Development of squamous cystic tissues from hPSCs in the Gel-3D niche requires 
a thick gel bed. (a) Confocal micrographs showing staining of WGA (purple), NANOG (red), 
OCT4 (green), and SOX2 (red) and counterstaining by HOECHST (blue) for hPSCs cultured 
in Gel-3D with varying nominal gel bed thicknesses as indicated. Cartoons show the typical 
epithelial cyst morphology observed under each condition. Scale bar, 50 µm. (b) Stacked bar 
plot showing percentages of hPSC-derived epithelial cysts with different morphologies in Gel-
3D as a function of the nominal gel bed thickness. Data represent the mean ± s.e.m with ncyst = 
306, 361, 694, and 492 for gel beds of 20, 60, 100, and 150 µm thickness, respectively. n = 3 
biological replicates for each condition. n = 2 independent experiments. 
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Figure 2-9 Self-organized development of epithelial cystic tissue with squamous, human 
amnion-like morphology by hPSCs cultured on an artificial matrix containing an elastomeric 
micropost array. (a) Scanning electron microscopy (SEM) image of the elastomeric 
polydimethylsiloxane (PDMS) micropost array with a post diameter of 1.83 µm, a post height 
of 8.4 µm, and a post center-to-center distance of 4 µm. Scale bar, 10 µm. (b) Specifics (top) 
and cartoons (middle) showing culture conditions containing an artificial matrix made of 
PDMS microposts with different post heights to modulate substrate rigidity. Confocal 
micrographs (bottom) showing epithelial morphology (stained by WGA, purple, or ECAD, 
green) and co-staining of NANOG (red), OCT4 (green), and SOX2 (red) for hPSCs cultured 
in indicated conditions. HOECHST (blue) counterstains the nucleus. For the squamous cyst 
formed in 3D on 8.4 µm tall microposts (right), confocal micrographs taken at two planes 
passing the middle (P1) and bottom (P2) of the cyst (white dashed lines in cartoon) are 
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cysts might be sensitive to the apparent mechanical stiffness of the gel bed. In order to test this 
hypothesis, gel beds of different thickness, namely, 20, 60, 100, and 150 µm, were used in the 
Gel-3D culture condition. Interestingly, at day 5, lumenal epithelial cysts formed by hPSCs on 
gel beds of 100 µm and 150 µm thickness exhibited predominantly a flat, squamous morphology; 
while those cultured on thinner gel beds of 20 and 60 µm thickness displayed mainly columnar 
epithelial morphology (Figure 2-8). This observation supports that the squamous cystic tissue 
morphogenesis is mechano-sensitive and requires a soft 3D ECM environment.  
 To further confirm the physical niche-dependency of hPSC morphogenic cytodifferentiation, 
we adopted an artificial matrix, made of a regular array of elastomeric polydimethylsiloxane 
(PDMS) microposts70 whose height can be precisely modulated to control substrate rigidity and 
surface area (Figure 2-9a,b). Consistently, spontaneous development of squamous cysts occurred 
only in hPSCs cultured on 8.4 µm tall microposts (a soft matrix), but not on 0.7 µm tall 
microposts or on flat PDMS surfaces (rigid matrices), even though all included a 3D GeltrexTM 
overlay (Figure 2-9b,c). Interestingly, hPSCs cultured on soft 8.4 µm tall microposts in 2D (i.e., 
without the GeltrexTM overlay) did not form cysts (Figure 2-9b), in contrast to columnar cysts 
formed in Gel-2D (Figure 2-3a,b). The mechanism underlying this differential morphogenesis is 
yet unknown, but it is speculated to be due to the mechanical property difference between an 
isotropic gel bed and an anisotropic micropost array. This question is worthy of further study.  
shown. The yellow square highlights ECAD+ protrusions (white arrowheads) at the interface 
between the cyst and microposts. Scale bar, 50 µm. (c) Stacked bar plot showing percentages 
of hPSC colony or hPSC-derived epithelial cysts with different morphologies as a function of 
PDMS micropost height and ECM dimensionality. Flat PDMS surfaces without microposts 
(thus with a micropost height of 0 µm) were included for comparison. Data represent the 
mean ± s.e.m with ncolony = 100 for all three 2D culture conditions and ncyst = 250, 270, and 
282 for 3D cultures using flat PDMS, 0.7 µm tall micropost, and 8.4 µm tall micropost, 
respectively. n = 3 biological replicates for each condition. n = 3 independent experiments. 
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2.4.4 The Squamous Cystic Tissue is Not of Other Non-Amniotic Lineages 
 In order to elucidate the cell fate of the hPSC-derived squamous cystic tissue, its molecular 
signature was examined and compared with that of other embryonic and extraembryonic lineages 
possibly existing in a peri-implantation embryo, including primitive streak (PS), neuroectoderm, 
primordial germ cells (PGCs), primitive endoderm (PE)/hypoblast, trophectoderm 
(TE)/trophoblast, and amnion.  
 Primitive streak development is associated with an epithelial-to-mesenchymal transition 
(EMT) accompanied by the up-regulation of transcription factors including BRACHYURY 
(BRA), SNAIL, and SLUG76. Indeed, basal protrusions observed in the squamous cysts (Figure 
2-3b) suggest the possible involvement of EMT. Compared with control hPSCs in Glass-2D, up-
regulation of BRA/BRA and SLUG/SNAI2, but not SNAIL/SNAI1, were observed in squamous 
cysts in Gel-3D; no up-regulation of these transcription factors was seen in Gel-2D or Glass-3D 
conditions (Figure 2-10). In contrast, hPSC-derived PS cells (via a 2D culture protocol73; 
referred to henceforth as PS-2D cells) showed up-regulation of BRA/BRA, SNAIL/SNAI1, and 
SLUG/SNAI2 (Figure 2-10). PS-2D cells also showed a pronounced decrease in ECAD/CDH1 
and loss of ECAD organization, accompanied by increased NCAD/CDH2; none of these changes 
were seen in hPSC-derived squamous cysts (Figure 2-11). These data suggest that while PS-2D 
cells exhibit molecular signatures of canonical EMT (Figure 2-12a), the development of 
squamous cysts activates a unique subset of EMT-related transcription factors, notably without 
SNAIL, and elicits a columnar-to-squamous epithelial transition with ECAD/NCAD regulation  
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Figure 2-10 The development of squamous cystic tissues activates a unique subset of 
epithelial-to-mesenchymal transition related transcription factors. (a) Confocal micrographs 
showing immunostaining of BRACHYURY (BRA, red; top), SNAIL (red; middle), and SLUG 
(red; bottom) in hPSCs cultured under indicated conditions and corresponding staining of 
primitive streak (PS) cells derived from hPSCs under 2D culture73 (PS-2D). HOECHST (blue) 
counterstains the nucleus. Scale bar, 50 µm (b) qRT-PCR analysis of BRACHYURY (BRA), 
SNAI1, and SNAI2, for hPSCs cultured in indicated conditions. Data were normalized against 
GAPDH and plotted as the mean ± s.e.m, with n = 3 - 5 biological replicates indicated by 
individual dots under each condition, n = 2 independent experiments. P-values were calculated 
using unpaired, two-sided Student's t-tests. *: P < 0.05; **: P < 0.01; ***: P < 0.001.  
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distinct from that observed in canonical EMT and PS lineage differentiation (Figure 2-12b). 
Additionally, FOXA2/FOXA2 , a PS/endoderm marker, was undetectable in squamous cysts 
(Figure 2-13), further excluding the PS lineage. Absence of SOX2 - a marker of human 
neuroepithelium77 - in squamous cysts (Figure 2-4) excludes the neuroectodermal lineage. A 
recent publication suggests that PGCs develop by canonical EMT from nascent amniotic cells in 
the monkey embryo19. As shown above, the molecular profile of squamous cysts indicates the 
absence of a canonical EMT program, excluding the PGC lineage. In addition, expression of 
SOX17, which is another marker of PGCs, was not observed in the squamous cyst either (data 
not shown). However, it remains a future goal to determine whether PGCs can be derived from 
the squamous cysts with a suitable protocol. 
 
 
Figure 2-11 Squamous cysts exhibit distinct regulation on CADHERINs. (a) Confocal 
micrographs showing immunostaining of ECAD (green; top) and N-CADHERIN (NCAD, red; 
bottom) for hPSCs under indicated culture conditions. HOECHST (blue) counterstains the 
nucleus. Scale bar, 50 µm. n = 2 independent experiments. (b) qRT-PCR analysis of CDH1, 
and CDH2, for hPSCs cultured in indicated conditions. Data were normalized against GAPDH 
and plotted as the mean ± s.e.m, with n = 3 - 5 biological replicates indicated by individual dots 
under each condition, n = 2 independent experiments. Data in b for CDH1 under both Glass-
2D and Gel-3D conditions are the same as those in Figure 2-5b. P-values were calculated using 
unpaired, two-sided Student's t-tests. **: P < 0.01; ***: P < 0.001. 
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  In addition, PE/hypoblast markers GATA4 and GATA616 were not up-regulated in squamous 
cysts either, compared with hPSCs, excluding the PE lineage (Figure 2-14a). Interestingly, 
several TE/trophoblast markers - GATA2, GATA3,CDX2, and TP6316,78 - were highly up-
regulated in squamous cysts compared with hPSC colonies and columnar cysts (Figure 2-14b). 
However, other known trophoblast markers - KRT7, CGA, HLA-G78,79 - were not up-regulated in 
 
Figure 2-12 Schemes summarizing the paradigms of canonical epithelial-to-mesenchymal 




Figure 2-13 The squamous cystic tissue does not express FOXA2, a PS/endoderm marker. (a) 
Confocal micrographs showing immunostaining of FOXA2 (red) and counterstaining by 
HOECHST (blue) for hPSCs cultured in Glass-2D, Gel-3D, and PS-2D conditions as 
indicated. Scale bar, 50 µm. n = 2 independent experiments. (b) qRT-PCR analysis of FOXA2 
for hPSCs cultured in different conditions as indicated. Data were normalized against GAPDH 
and plotted as the mean ± s.e.m, with n = 3 - 5 biological replicates indicated by individual 
dots under each condition. P-values were calculated using unpaired, two-sided Student's t-test. 
***: P < 0.001. n = 2 independent experiments. 
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squamous cysts (Figure 2-15a). The squamous cysts showed heterogeneous staining of CDX2 
and GATA3, both of which co-localize with BRA (Figure 2-15b,c), combinations not seen in 
hPSC-derived trophoblasts78. SSEA-4, a surface antigen associated with the inner cell mass, but 
not TE80, is also retained in squamous cysts (Figure 2-15d). Importantly, other studies have 
reported GATA2, GATA378,81, and SSEA-418,82 expression in human amnion. Together, these 
results contradict known molecular features of trophoblasts, and suggest that the hPSC-derived  
 squamous cysts formed in the implantation-like Gel-3D niche might resemble human amnion. 
 
Figure 2-14 The squamous cystic tissue express extraembryonic tissue markers. qRT-PCR 
analysis of primitive endoderm/hypoblast markers GATA4 and GATA6 (a), and conventional 
trophectoderm and trophoblast markers GATA2, GATA3, CDX2, and TP63 (b). 
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Figure 2-15 hPSC-derived squamous cystic tissue lacks molecular features associated with 
trophoblasts. (a) qRT-PCR analysis of trophoblast markers KRT7, CGA, and HLA-G, for 
hPSCs under different culture conditions as indicated. Data were normalized against GAPDH 
before being plotted as the mean ± s.e.m, with n = 3 biological replicates indicated by 
individual dots for each condition. n = 2 independent experiments. P-values were calculated 
using unpaired, two-sided Student's t-test. *: P < 0.05. (b&c) Confocal micrographs showing 
co-staining of BRA (red) with CDX2 (green; b) or GATA3 (green; c), for hPSCs under both 
Glass-3D and Gel-3D culture conditions. HOECHST (blue) counterstains the nucleus. n = 2 
independent experiments. (d) Confocal micrographs showing co-staining of SSEA-4 (green) 
with SOX2 (red) for hPSCs cultured in different conditions as indicated. HOECHST (blue) 
counterstains the nucleus. n = 2 independent experiments. Scale bars in b-d, 50 µm.  
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2.4.5 The Squamous Cystic Tissue Exhibits Molecular Signatures of Early Human Amnion 
 As shown in Figure 2-16a, mRNA expression of a set of key fate-identifying genes recently 
reported for first trimester human amnion - ITGB6, VTCN1, GABRP and MUC1681 - are all 
significantly up-regulated in squamous cysts compared with control hPSCs. Additionally, 
squamous cysts exhibit up-regulated expression of HAND1, POSTN, TFAP2A, and TFAP2B 
(Figure 2-16b); HAND1, POSTN, and TFAP2A are early amnion markers in the mouse embryo83, 
and POSTN, TFAP2A, and TFAP2B are reported first trimester human amnion markers81,83,84. 
The squamous cysts also show up-regulation of KRT17 and KRT18 (Figure 2-16c), which are 
observed in week 10 human amnion85. Together, these data demonstrate that, among all the 
candidate lineages, the hPSC-derived squamous cysts exhibit a molecular signature most closely 
matching known aspects of human amnion at the first trimester (e.g., week 9-10), the earliest 
stage reported so far in the literature. 
Figure 2-16 qRT-PCR analysis of squamous cysts for first trimester human amnion markers 
ITGB6, VTCN1, GABRP, MUC16, HAND1, POSTN, TFAP2A, TFAP2B, KRT17, and KRT18. 
All data were normalized against GAPDH and plotted as the mean ± s.e.m, with n = 3 - 5 
biological replicates indicated by individual dots, n = 2 independent experiments. P-values 
were calculated using unpaired, two-sided Student's t-tests. *: P < 0.05; **: P < 0.01. 
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2.4.6 Profiling the Transcriptome of hPSC-derived Amnion-like Tissue by RNA-sequencing 
 To establish the transcriptome of the hPSC-derived amnion-like tissue (referred to 
henceforth as hPSC-amnion), we performed RNA-sequencing (RNA-seq) (see GEO deposit 
GSE89479). Although the transcriptome of hPSC-amnion differs substantially from that of 
control hPSCs, the expression levels of a cohort of putative pluripotency genes86 (Table D-1) are 
remarkably similar in both; only CUZD1 and CCL26 are substantially down-regulated in hPSC-
amnion compared with control hPSCs (Figure 2-17). This observation suggests that hPSC-
amnion develops with only slight down-regulation of the transcriptional circuitry maintaining 
pluripotency, consistent with the emergence of amnion from expanding pluripotent epiblasts in a 
self-renewal-permissive environment in vivo and here in vitro.  
 We next selected ~4,000 genes with higher expression in hPSC-amnion than in hPSCs or in 
previously examined fetal extraembryonic tissues, including amnion, chorion, and umbilical cord 
(GEO access number GSE66302)81 (Figure 2-18), and subjected them to hierarchical clustering. 
This revealed a gene set uniquely enriched in hPSC-amnion and relatively depleted in hPSCs and 
 
Figure 2-17 The development of squamous cysts shows limited perturbation on putative 
pluripotency genes. Heat map showing expression levels of 108 putative pluripotency genes86 
(Table D-1), 50 most up-regulated genes (UP-50), and 50 most down-regulated genes 
(DOWN-50) (Table E-1) in hPSC-amnion derived in Gel-3D relative to hPSC colonies in 




other extraembryonic fetal tissues (Figure 2-18). Thus, this unique molecular signature probably 
reflects the fact that the peri-implantation stage represented by hPSC-amnion is developmentally 
earlier than any of previously examined amnion tissues78,81,84.  We also compared the genes 
enriched in hPSC-amnion with the recently reported single cell transcriptomes of 197 non-
amniotic cells obtained from post-implantation monkey embryos8. This analysis did not reveal 
any single monkey cell that displays a transcriptome similar to hPSC-amnion (data not shown),  
further supporting our contention that the hPSC-amnion described here represents a distinct 
lineage. We should also note that the hPSC-amnion, which resembles the initial stage of amnion 
 
Figure 2-18 A unique gene set enriched in hPSC-amnion. (left) Hierarchical clustering of 
~4,000 hPSC-amnion-enriched genes among hPSC colonies (Glass-2D), hPSC-amnion (Gel-
3D), and published fetal extraembryonic tissues including week 9 amnion and umbilical cord 
(Amn9, Umb9), week 16 amnion and chorion (Amn16, Chor16), week 18 amnion (Amn18), 
and week 22 amnion and chorion (Amn22, Chor22)81. (right) Zoom-in view of hPSC-amnion 
enriched genes. The color scale represents levels of normalized gene expression. 
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development in human, is the end-point phenotype in the current culture system (data not shown),  
suggesting that it may require additional factors for further development of the amnion-like 
tissue in vitro.  
 To further characterize the hPSC-amnion, we performed gene ontology (GO) functional 
annotation clustering for genes enriched in hPSC-amnion relative to hPSCs. GO terms for genes 
enriched in 9-week human amnion as well as human chorion and placenta (relative to hPSCs) 
were similarly clustered. Strikingly, three most enriched annotation clusters in hPSC-amnion 
were transcription factors, primarily those of the homeobox classes (Figure 2-18). Interestingly, 
HOX genes comprised the highest ranked cluster in 9-week amnion as well (Figure 2-18). 
 
Figure 2-19 Gene ontology (GO) functional annotation clustering. Genes enriched in hPSC-
amnion, 9-week human amnion, human chorion, and human placenta, respectively, relative to 
hPSCs, were subjected to functional annotation clustering analysis using DAVID. For each 
data set, the four annotation clusters with the highest enrichment scores (plotted along the x-
axis and also listed in parentheses following the annotation term) are presented. The data sets 
used for 9-week human amnion, human chorion, and human placenta are from a previous 
publication (GEO accession number GSE66302)81. 
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2.4.7 BMP-SMAD Signaling is Endogenously Activated and Required for hPSC Amniogenesis 
 Among genes enriched in hPSC-amnion were several potential BMP targets including 
DLX5/6 and EVX1 (Figure 2-18, Table E-1). Gene set enrichment analysis (GSEA) also revealed 
significant enrichment of genes related to the ALK-pathway, which is associated with BMP 
signaling, in hPSC-amnion compared with hPSCs (Figure 2-20). Indeed, we observe prominent 
nuclear staining and up-regulated protein level of phosphorylated SMAD1/5 (pSMAD1/5), a 
 
Figure 2-20 Gene set enrichment analysis (GSEA) for ALK-pathway hPSC-amnion. The 
entire ranked list of genes, ordered by fold change of expression level in hPSC-amnion relative 
to hPSCs (as shown in GEO deposition GSE89479), was queried using the gene set, 
BIOCARTA_ALK_PATHWAY, which contains 35 genes associated with BMP signaling. 
Significant enrichment of ALK-pathway related genes was observed in hPSC-amnion. (see 
Table F-1 for tabulated enrichment analysis results).  
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downstream target of BMP-SMAD signaling, in hPSC-amnion, compared with control hPSC 
colonies and columnar cysts (Figure 2-21). It suggests that BMP-SMAD signaling is activated 
during hPSC-amnion development, consistent with findings in early mouse embryos83,87,88 and 
post-implantation monkey embryos19. Consistently, both RNA-seq and qRT-PCR analysis 
(Figure 2-22a) show up-regulated BMP2/4/7 in hPSC-amnion. Western blotting further confirms 
significantly increased BMP4 protein level in hPSC-amnion (Figure 2-22b), consistent with 
endogenously activated BMP-SMAD signaling during the development of hPSC-amnion in the 
implantation-like biophysical niche.  
 To examine whether BMP-SMAD signaling is required for hPSC-amnion development, 
hPSCs cultured in Gel-3D were treated with a small molecule inhibitor LDN193189 (LDN), 
which inhibits ALK2/3 receptors that bind to BMP2/4/7. Strikingly, short-term treatments with 
LDN (on day 2 only or on both days 2 and 3) were sufficient to inhibit hPSC-amnion 
development (Figure 2-23, 2-24). The development of hPSC-amnion is also inhibited by 
treatment with NOGGIN, a BMP-specific antagonist protein (Supplementary Fig. 11d&e). 
Together, these results implicate the requirement of endogenous BMP-SMAD signaling for 
hPSC-amnion development. It remains to be determined how physical signals from the 3D 




Figure 2-21 The development of hPSC-amnion activates BMP-SMAD signaling. (a) Confocal 
micrographs showing immunostaining of phosphorylated SMAD1/5 (pSMAD1/5, red) in 
hPSCs cultured under indicated conditions. HOECHST (blue) counterstains the nucleus. n = 2 
independent experiments. Scale bar, 50 µm. (b) Western blot showing protein levels of 
pSMAD1/5, SMAD1/5/8, and GAPDH for hPSCs cultured under indicated conditions. n = 3 
independent experiments.  
 
Figure 2-22 The development of hPSC-amnion activates endogenous BMP production. (a) 
qRT-PCR analysis of BMP2, BMP4, BMP6, and BMP7 for hPSCs cultured under indicated 
conditions. Data were normalized against GAPDH and plotted as the mean ± s.e.m, with n = 4 - 
5 biological replicates indicated by individual dots, n = 2 independent experiments. P-values 
were calculated using unpaired, two-sided Student's t-tests. *: P < 0.05; **: P < 0.01; ***: P < 
0.001. (b) Western blot showing expression levels of BMP4 and GAPDH in hPSCs cultured 








Figure 2-23 Inhibition of BMP receptors prevents the spontaneous differentiation of hPSC-
amnion. (a) Confocal micrographs showing immunostaining of NANOG (red; top), OCT4 
(green; middle), SOX2 (red; bottom), pan-cell membrane marker WGA (purple; top and middle), 
and basolateral membrane marker ECAD (green; bottom), in hPSC-derived epithelial cysts 
under Glass-3D and Gel-3D conditions with or without supplementation of BMP inhibitor 
LDN193189 (LDN) as indicated. LDN was supplemented on either day 2 only (LDN-d2) or on 
both days 2 and 3 (LDN-d2&3). n = 4 independent experiments. Scale bar, 50 µm. (b) Stacked 
bar plot showing percentages of hPSC-derived epithelial cysts with different morphologies in 
Glass-3D supplemented with DMSO (Glass-3D; negative control), in Gel-3D supplemented with 
DMSO (Gel-3D; positive control), and in Gel-3D supplemented with LDN193189 (LDN; 500 
nM) on day 2 only (LDN-d2) or on both days 2 and 3 (LDN-d2&3). ncyst = 144, 311, 365, and 
320 for Glass-3D, Gel-3D, LDN-d2, and LDN-d2&3, respectively. n = 3 biological replicates 








Figure 2-24 Inhibition of BMP receptors suppresses the up-regulation of amniotic markers in 
Gel-3D condition. qRT-PCR analysis of GATA2, GATA3, CDX2, TP63, BMP4, ITGB6, 
VTCN1, GABRP, MUC16, HAND1, and POSTN under Glass-3D, Gel-3D, LDN-d2, and LDN-
d2&3 conditions. Data were normalized against GAPDH and plotted as the mean ± s.e.m, with 
n = 4 biological replicates indicated by individual dots for each condition. n = 2 independent 
experiments. ND, not detected, with its normalized value set to zero. P-values were calculated 
using unpaired, two-sided Student's t-test. P-value calculation was not performed against "ND" 
result. *: P < 0.05; **: P < 0.01; ***: P < 0.001.  
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2.4.8 Discussion 
 Although the histology of early human amnion development has been documented for more 
than half a century in the Carnegie collection of human embryos, it remains mysterious thus far 
how amniogenesis is induced from the epiblast and what developmental signaling is involved in 
such process. Findings reported in this work have brought new insights to answer those questions. 
Specifically, this work showed that amnion-like epithelial cells can arise from hPSCs through an 
apparent columnar-to-squamous morphological transition, suggesting that a similar process, 
which does not elicit canonical EMT but a unique subset of EMT-related transcription factors, 
might be involved during the emergence of amnion from pluripotent epiblast. In addition, this 
work showed that the amniogenic differentiation requires endogenous BMP production and 
 
Figure 2-25 Development of hPSC-amnion can be inhibited by NOGGIN, a BMP antagonist 
protein. (a) Immunofluorescence analysis of cysts cultured under Gel-3D condition without 
(top) or with (bottom) NOGGIN treatment. Cysts were stained for OCT4 (green), SOX2 (red), 
and WGA (purple). HOECHST (blue) counterstains the nucleus. Scale bar, 50 µm. (b) Stacked 
bar plots show percentages of hPSC-derived epithelial cysts with different morphologies in the 
Gel-3D system without ("Gel-3D" group) or with ("NOGGIN" group) NOGGIN treatment. 
ncyst = 131 and 241 for Gel-3D and NOGGIN groups, respectively. Data represent the mean ± 
s.e.m. with n = 3 biological replicates from n = 2 independent experiments. 
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subsequent BMP-SMAD signaling within the amniotic cells, suggesting a potentially self-
organizing and self-sustaining development of amnion in humans. This finding could challenge 
the traditional dogma that exogenous BMP ligand, likely from extraembryonic tissues (such as 
trophoblast) adjacent to the epiblast, is required for inducing amnion development in humans17. 
It also suggests that peri-implantation amnion could be a source of BMP ligand for additional 
embryonic induction of other tissues. This is consistent with recent report by Sasaki et al. that 
nascent amnion might be a paracrine center providing BMP ligand for PGC induction in monkey 
embryos19.  
 In the last 5 years, there has been intensive interest and rapid progress in developing human 
organogenesis models in vitro using cultured hPSCs26,49. Paradoxically, it remains unclear 
whether hPSCs, which reside in a peri-implantation epiblast-like state, can be applied to model 
human-specific, peri-implantation developmental events in vitro. This work provides the first 
successful demonstration of applying hPSCs to study pre-gastrulation, peri-implantation human 
embryonic development - amniogenesis. Results reported in this chapter could broaden our 
understanding of the biology and developmental potential/competence of hPSCs, and expand the 
application of hPSCs into an uncharted field - implantation human embryology - that we 
envisage to further explore in future. 
 hPSCs, like many other cell types, have been found to be sensitive to microenvironmental 
physical factors and can change their behaviors, such as lineage differentiation, accordingly. 
Previous studies on the mechanobiology of hPSCs have suggested that individual biophysical 
cues, such as substrate softness, in the stem cell niche may be sufficient to promote uncontrolled 
spontaneous differentiation of hPSCs in 2D culture89. However, findings reported in this chapter 
challenged this classic view of hPSC mechanobiology, by showing that no notable amniogenic 
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differentiation of hPSCs occurs when only a 2D soft substrate is applied under biochemical 
conditions that permit hPSC self-renewal. Instead, as this work demonstrated, the integration of 
multiple implantation-like biophysical niche cues, including both 3D ECM and matrix softness, 
is required to efficiently switch hPSCs towards amniogenesis from an otherwise self-renewal 
state. Moreover, this work established that these biophysical niche cues are both necessary and 
sufficient to initiate the autonomous BMP-SMAD signaling required for amniogenesis. These 
findings might revises our current knowledge of the mechanobiology of hPSCs and its 
application in understanding developmental biomechanics and tissue engineering in future. 
   
2.5 Conclusions 
 This chapter reports a biomimetic implantation-like niche for hPSCs to model human 
amniogenesis - a key developmental step previously not accessible to study. This chapter 
demonstrated that amniotic development by hPSCs is a self-organizing process that occurs in the 
absence of biochemical inductive cues from a maternal or extraembryonic source. Rather, 
physical signals from the implantation-like niche are necessary and sufficient to trigger the 
development of amnion-like tissue. This chapter revealed that the development of hPSC-amnion 
relies on an autonomously activated BMP-SMAD signaling as well as endogenous production of 
a unique subsets of BMP ligand. Interestingly, while the squamous hPSC-amnion reported here 
closely resembles human amnion tissue from morphological and transcriptomic perspectives, 
they do not fully recapitulate the patterned tissue morphologies of the peri-implantation human 
embryo, which will be addressed in the next chapter. This chapter also highlighted a previously 
unknown developmental potential of hPSCs and therefore opened new avenues for the 
application of hPSCs for human developmental modeling. In addition to advancing fundamental 
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understanding of human amnion development and expanding the application of hPSCs to model 
peri-implantation human embryogenesis, this efficient hPSC-based 3D amniogenic system could 
be leveraged for developing high-throughput screening assays to predict human reproductive 
success, examine the effect of toxins on amniotic development, or provide a therapeutic strategy 
for in utero treatment of amniotic tears. This efficient amniogenic induction system could also 
facilitate large-scale bio-fabrication of wound-healing-competent human amniotic cells for 
clinical applications.‡  
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Amniotic Sac Embryoid: an in vitro Model for Early Human 
Amniotic Sac Development 
3.1 Introduction 
 The amniotic sac - an asymmetrically patterned epithelial cyst that encloses the amniotic 
cavity with squamous amnion at one pole and columnar epiblast at the other - is a key 
developmental structure arise from embryonic inner cell mass during the implantation of human 
embryo6 (Figure 3-1). It also sets the stage for gastrulation beginning at d.p.f. 13.Despite earlier 
histological studies6 and recent in vitro cultures of early human embryos16,17, the development of 
human amniotic sac remains mysterious to date, due to a lack of in vitro models that can 
recapitulate its distinct morphogenesis and cell fate patterning during human embryogenesis 
from implantation to early gastrulation.  
 Human pluripotent stem cells (hPSCs), which share significant similarity with pluripotent 
 
Figure 3-1 Cartoon of an implanting human embryo.  
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epiblast in the human embryo9,23,90, have been successfully utilized for modeling post-
gastrulation human development in vitro14,25,45,49,51. In Chapter II, in order to expand the 
application of hPSCs to model human development during implantation, we developed a 
biomimetic in vitro culture system that implements two implantation niche-inspired biophysical 
cues - an underlying soft tissue/gel bed and an overlaying three dimensional (3D) extracellular 
matrix (ECM). We demonstrated that even in the absence of extraembryonic tissues and 
exogenous biochemical inductive factors, this culture system efficiently induces spontaneous 
development of hPSCs to squamous epithelial cysts, which exhibit molecular characteristics of 
early human amnion. This chapter will further explore such an implantation-like culture system 
and address the question whether hPSCs can develop into a more sophisticated 3D structure 
modeling the development of the amniotic sac in human - including its morphogenic dynamics, 
cell fate partitioning, and the patterning of cell signaling - at implantation and gastrulation.†† 
 
3.2 Materials and Methods 
3.2.1 Fabrication of Basement Membrane Matrix Gel Beds 
 The GeltrexTM gel bed was generated based on a "sandwich" setup developed in the last 
chapter. In brief, a 22 × 22 mm2 glass coverslip ("attaching substrate") was treated with air 
plasma (Harrick Plasma) for 2 min, before coated with 0.1 mg ml-1 poly-(L-lysine) (PLL) 
solution (Sigma-Aldrich) for 30 min and then 1% glutaraldehyde solution (Electron Microscopy 
Sciences) for another 30 min. To prepare a "releasing substrate", a pre-cleaned glass slide was 
activated by air plasma for 2 min, and then coated with 0.1 mg ml-1 poly-(L-lysine)-graft-poly-
                                                 
†† The results presented in this chapter are adapted from a manuscript that we recently submitted.  
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(ethylene glycol) (PLL-g-PEG; SuSoS) solution for 1 h. To obtain gel beds with a nominal 
thickness of 100 µm, 50 µl undiluted GeltrexTM was sandwiched between the attaching and 
releasing substrate on ice before incubated at 37°C for 30 min. The gel bed, attached to the 
attaching substrate, was then peeled from the releasing substrate before submerged in 
DMEM/F12 medium (Thermo Fisher Scientific) and incubated at 37°C overnight before plating 
cells. To prepare gel beds with a nominal thickness larger than 100 µm, spacers made of 
polydimethylsiloxane (PDMS; Dow Corning) films were placed between the attaching and 
releasing substrates when preparing the gel bed sandwich. The PDMS film was generated by 
spin-coating liquid PDMS (mixed at a 10:1 ratio between PDMS base and curing agent) onto a 
petri-dish at 500 rpm for 40 s (for generating 150 µm thick PDMS film used in this study) and 
cured at 70°C for at least 24 h before use. 
3.2.2 3D hPSC Culture 
 In brief, cultured hPSCs were dissociated with Accutase (Sigma-Aldrich) at 37°C for 10 min 
before suspended in PBS as single cells. hPSCs were centrifuged before resuspended in mTeSR1 
containing 10 µM Y27632 (Tocris). hPSCs were plated as single cells at 30,000 cells cm-2 onto a 
thick gel bed with nominal thickness ≥ 100 µm. After 24 h (on day 1), culture medium was 
replenished with fresh mTeSR1 without Y27632, and 4% (v:v) GeltrexTM was supplemented in 
the medium as previously described for 3D culture63. Thereafter, mTeSR1 medium was 
replenished daily, and 4% (v:v) GeltrexTM was supplemented daily till day 5, unless otherwise 
noted. 
3.2.3 Derivation of Anterior, Posterior, and Late Primitive Streak Cells 
 Anterior, posterior and late primitive streak (PS) cells, respectively, were derived from 
hPSCs by adapting previously published protocols73. In brief, hPSCs were dissociated as single 
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cells before plated at 25,000 cm-2 in Essential 8TM medium (E8; Thermo Fisher Scientific) 
containing 10 µM Y27632 onto glass coverslips that were thinly coated with 1% GeltrexTM 
solution. On day 1, the medium was replenished with fresh E8. On day 2, the medium was 
replaced with anterior PS, posterior PS, and late PS differentiation medium, respectively, with 
the following composition: (1) anterior PS differentiation medium: Essential 6TM medium (E6; 
Thermo Fisher Scientific) + 20 ng ml-1 FGF2 (Peprotech) + 10 µM LY294002 (Tocris) +25 ng 
ml-1 BMP4 (R&D Systems) + 50 ng ml-1 Activin A (R&D Systems); (2) posterior PS 
differentiation medium: E6 + 20 ng ml-1 FGF2 + 10 µM LY294002 + 50 ng ml-1 BMP4; (3) late 
PS differentiation medium: E6 + 20 ng ml-1 FGF2 + 8 µM CHIR99021 (Tocris). All 
differentiations were induced for 48 h before downstream analyses. 
 
Figure 3-2 A small fraction of self-organized cysts exhibit asymmetric morphology in the 
biomimetic implantation-like culture. (a) Cartoon and confocal micrographs showing a 
representative squamous cyst (top) and a representative asymmetric cyst (bottom) stained for 
ECAD (red) and HOECHST (blue). Scale bar, 50 µm. (b) Bar plot showing percentages of 
squamous and asymmetric cysts in the 3D implantation-like culture. n = 1,728 and 78 for 
squamous and asymmetric cysts, respectively, out of total 1,924 cysts from 3 biological 
replicates. Data represent the mean ± s.e.m. The rest of 124 cysts exhibited a columnar 





3.3 Results and Discussion 
3.3.1 Discovery of hPSC-derived Asymmetric Cysts in the Implantation-like Niche 
 In Chapter II, we demonstrated that the 3D implantation-like biophysical niche could 
efficiently and robustly induce amniogenic differentiation of hPSCs. Such amniogenic induction 
system provides the critical component - amnion - for the development of the amniotic sac. 
Intriguingly, on day 5, while the majority of cysts formed in the implantation-like niche have 
adopted squamous epithelial morphology, we consistently observed a small population of 
asymmetric cysts in this 3D culture system (Figure 3-2), suggesting concomitant development of 
a structure more complex than the simple squamous amnion cyst.  
3.3.2 The Asymmetric Cyst Morphologically Resembles Peri-implantation Human Amniotic Sac 
 These asymmetric cysts are E-CADHERIN+/β-CATENIN+ (ECAD+/bCAT+) epithelial 
sacs composed of tall, columnar cells on one side, and flattened, squamous cells on the other 
(Figure 3-3a). They are also apico-basally polarized with EZRIN+, WGA-enriched apical 
surfaces facing inward (Figure 3-3b). Intriguingly, these asymmetric cysts are morphologically 
reminiscent of the amniotic sac in peri-implantation human embryos at Carnegie stages 5a-2, 5b, 
and 5c, on day past fertilization (d.p.f.) 8, 9, and 12, respectively (Figure 3-3c). Specifically, the 
squamous-columnar morphological transition in asymmetric cysts mirrors the amnion-epiblast 
partitioning in human amniotic sac, as revealed by quantitated tissue/region-specific nuclear 
dimension and epithelial thickness (Figure 3-3d,e). Notably, such asymmetric cyst frequently 
forms with the squamous side oriented towards the gel bed (Figure 3-4), reminiscent of the 
development of squamous amnion in proximity to the maternal tissue in implanting human 
embryos6 (Figure 3-1).  
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Figure 3-3 The asymmetric cyst morphologically resembles peri-implantation human 
amniotic sac. (a&b) Confocal micrographs showing an ASE on day 5, stained with indicated 
markers. Scale bars, 50 µm. (c) Comparison between the Carnegie stage embryos and the 
asymmetric cyst (the images are the same as shown in Figure 1-3). Scale bars, 30 µm. (d&e) 
Tissue/region-specific measurements of normalized nucleus dimension (apico-basal : lateral 
dimension of nuclei) (d) and epithelium thickness (e) in human embryos and in the 
asymmetric cyst as indicated. Box: 25-75%, bar-in-box: median, and whiskers: 1 and 99%.  
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3.3.3 The Columnar Pole of the Asymmetric Cyst Resembles the Embryonic Disc 
 The columnar side of the asymmetric cyst is composed of cells that prominently retain 
pluripotency marker OCT4 (also known as POU5F1), which is lost in the squamous cells (Figure 
3-5a). Co-staining OCT4 with other pluripotency markers - NANOG and SOX2, respectively - 
confirms that the columnar side of the asymmetric cyst is generally composed of undifferentiated, 
epiblast-like hPSCs (Figure 3-5b). Such columnar epithelial structure expressing pluripotency 
markers OCT4, NANOG, and SOX2 resemble the embryonic disc lining at one pole of the 
amniotic sac in humans and other primates7,91 (Figure 3-3b). 
 
Figure 3-4 The asymmetric cyst frequently form with its squamous side oriented towards the 
underlying gel bed. (a) Schematic showing the definition of cyst orientation angle θ, which is 
negative when the squamous side of the cyst is closer to the gel bed. (b) Quantitated cyst 
orientation angle θ from n = 28 cysts. Box: 25-75%, bar-in-box: median, and whiskers: 1 and 
99%. Base line of θ = 0º is drawn (red dashed line) for reference. (c&d) X-Z confocal sections 
showing representative cysts stained for ECAD (red) and WGA (purple), with cyst orientation 




Figure 3-5 The columnar pole of the asymmetric cyst resembles the pluripotent embryonic 
disc. (a) 3D rendering of an asymmetric cyst on day 5, stained with indicated markers, flanked 
by X-Z (bottom) and Y-Z (right) views. Scale bar, 50 µm. (b&c) Confocal micrographs 
showing day 5 asymmetric cysts stained for OCT4 (green), NANOG (red), and WGA (purple) 
(b), and OCT4 (green), SOX2 (red), and WGA (purple) (b). HOECHST (blue) counterstained 
the nuclei. The OCT4+/NANOG+ and OCT4+/SOX2+ embryonic disc-like patterning 
resembles in vivo amniotic sac in Carnegie stage 5 human embryos as well as post-
implantation primate embryos91. Scale bars, 50 µm. 
 
 
Figure 3-6 Self-organized asymmetric cysts can be successfully generated using multiple 
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hPSC lines. Confocal micrographs showing day 5 asymmetric cysts derived from two hESC 
lines (UM63-1, top; H7, middle), and one hiPSC line (1196a, bottom) as indicated. The cysts 
were stained for OCT4 (green), NANOG (red) and WGA (purple). HOECHST counterstains 
the nuclei. Scale bars, 50 µm.  
 
3.3.4 The Squamous Pole of the Asymmetric Cyst Resembles the Amnion 
 The squamous side of the asymmetric cyst, in contrast, is composed of a flattened, 
differentiated epithelium that we recently identified as early human amnion-like tissue92. Indeed, 
TFAP2A and GATA3 - two markers for hPSC-derived early human amnion92 - are expressed 
only in squamous cells (Figure 3-7a,b). qRT-PCR analysis shows high mRNA levels for 
TFAP2A and GATA3 in week 16-17 human fetal amniotic epithelium, further supporting the 
contention that TFAP2A+/GATA3+ squamous cells molecularly resemble early human amniotic 
cells (Figure 3-7c). Together, these results show that hPSCs can spontaneously self-organize to 
form asymmetric epithelial cysts that recapitulate the peri-implantation amniotic sac in human, 
featuring an amniotic cavity lined by bi-polar amnion-epiblast patterning. Such hPSC-derived 
asymmetric cysts are thus termed amniotic sac embryoids (ASEs) henceforth (Figure 3-7d). 
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Figure 3-7 The squamous pole of the asymmetric cyst mimics the amnion. (a) Confocal 
micrographs showing an asymmetric cyst on day 5, stained with indicated markers. Scale bar, 
50 µm. (b) Confocal micrographs showing a day 5 asymmetric cyst stained for GATA3 
(green) and WGA (red), showing nuclear staining of GATA3 exclusively in the squamous 
cells. Scale bar, 50 µm. (c) qRT-PCR analysis of TFAP2A, GATA3, and SOX2 in week 16-17 
human fetal amniotic epithelial cells. Data were normalized against GAPDH and plotted as the 
mean ± s.e.m. with n = 3 biological replicates. P-values were calculated using paired, two-
sided Student's t-test. **: P < 0.01. (d) Schematic of the asymmetric cyst. The squamous side 
of the cyst, which expresses early human amnion markers, resembles the amnion lining the 
roof of the peri-implantation human amniotic sac. The columnar side of the cyst, which 
expresses pluripotency markers, recapitulates the embryonic disc composed of undifferentiated 
epiblast cells lining the floor of the peri-implantation human amniotic sac. The cavity enclosed 
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by the cyst thus resembles the amniotic cavity. Together, the asymmetric cyst models the 
morphology and cell-fate patterning of the amniotic sac in peri-implantation human embryo. 
The asymmetric cyst is thus termed the amniotic sac embryoid (ASE) henceforth. 
 
3.3.5 Amniotic Sac Embryoid Mimics the Developmental Trajectory of Human Amniotic Sac 
 We next examined the time course of ASE development. On day 2, most hPSCs form cysts 
that express both OCT4 and NANOG (Figure 3-8a). At this point, some cysts present an 
eccentrically positioned lumenal cavity; this represents the earliest stage of ASE development 
and resembles Carnegie stage 5a-1 (d.p.f. 7) embryo featuring a pro-amniotic cavity surrounded 
by polarized epiblast (Figure 3-8b). On day 3, two types of ASEs are present in the culture: one 
(type A, 20/46) exhibits slight loss of NANOG, but not OCT4, at the flattened amniotic pole, 
while the other (type B, 26/46) shows significant loss of both NANOG and OCT4, and a more 
flattened amniotic pole (Figure 3-8a). Together, day 3 ASEs exhibit the initiation and 
establishment of amnion-epiblast patterning in vitro and appear to recapitulate Carnegie stage 5a-
2 (d.p.f. 8) embryo (Figure 3-8b). Notably, the initiation of squamous, amnion-like tissue 
development in the ASE appears to be a continuous columnar-to-squamous morphological 
transition occurring at the amniotic pole, and no transient opening was observed at the 
amniogenic site, which challenges the previous dogma proposed by Luckett6. From day 4-5, 
ASEs maintain the amnion-epiblast patterning (Figure 3-8a) and resemble the growing amniotic 
sac from Carnegie stage 5a-2 to 5b (d.p.f. 9) and 5c (d.p.f. 12) (Figure 3-8b). The temporal 
trajectory of ASE development thus closely mimics the morphogenesis and cell-fate patterning 




Figure 3-8 Time-dependent trajectory of ASE development in vitro mimics peri-implantation 
human amniotic sac development in vivo. (a) Confocal micrographs showing ASEs from day 
2-5 stained for HOECHST (blue), OCT4 (green), NANOG (red), and WGA (purple). Since 
nuclear staining of NANOG typically exhibits heterogeneous intensity in cultured hPSCs, only 
cells in which nuclear staining of NANOG is completely absent were considered to have lost 
NANOG expression. (b) Carnegie stage (CS) 5a-13, 5a-24, 5b3, and 5c5 human embryos at 
d.p.f. 7, 8, 9, and 12, respective. Sections are obtained from the Virtual Human Embryo 
Project. The sections of CS5a-2, CS5b, and CS5c embryos are the same as shown in Figure 1-
3. A.C.: pro-amniotic cavity; Am.: (prospective) amnion; Epi.: epiblast. Scale bars, 30 µm. (c) 
Cartoon showing the time course of ASE development in vitro, compared with human 
amniotic sac development in vivo.  
 
3.3.6 ASEs Exhibit Phenotypic and Molecular Features Resembling Primitive Streak 
Development  
 Interestingly, on day 5, some ASEs (96/304) exhibit an additional phenotype, with single 
cells focally emigrating from, and only from, the embryonic disc lining the columnar pole 
(Figure 3-9a). In addition, epithelial structure and the expression of pluripotency markers OCT4 
and NANOG are disrupted around the cell egression site (Figure 3-9a). It is important to note 
that these locally emerging cells morphologically resemble primitive streak (PS) initiation in 
Carnegie stage 6 embryos at early gastrulation93 (Figure 3-9b). 
 To molecularly assess such gastrulation-mimicking development of ASEs, we examined the 
expression of BRACHYURY (BRA), a transcription factor associated with PS development94, in 
day 5 ASEs. By assessing and comparing the spatial distribution of BRA staining in different 
ASEs, we identified three distinct patterns of BRA expression based on which we define three 
consecutive stages of ASE development (Figure 3-10). Stage I (59/173) depicts ASEs that 
exhibit no cell dissemination and no prominent nuclear BRA in the embryonic disc. Stage II 
(56/173) defines ASEs that express nuclear BRA in the embryonic disc, but without cell 
emigration. Stage III (58/173) describes ASEs that show single cells emigrating from a BRA+, 
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PS-like region flanked by the embryonic disc (Figure 3-10). Immunofluorescence analysis of 
OCT4 confirms a stage-wise loss of pluripotency that parallelizes the formation of the BRA+, 
PS-like region (Figure 3-10). Together, these findings implicate that Stage I - III might represent 
a progressive developmental process wherein PS initiates within the epiblast at the loss of 
pluripotency, which eventually results in the emergence of mesenchymal-looking cells 
emigrating from the embryonic disc.  
 In order to further dissect the molecular distinction between Stage II and III, other than their 
phenotypic discrepancies, we examined the expression of CDX2 - a marker for posterior and late 
PS73 (Figure 3-11a) - in day 5 ASEs. Interestingly, CDX2 is expressed in the PS-like region in 
 
Figure 3-9 ASEs exhibit phenotype resembling primitive streak (PS) development. (a) 
Confocal micrographs showing single cells emigrating from the embryonic disc lining the 
columnar pole of an ASE on day 5, stained with HOECHST (blue), WGA (purple), OCT4 
(green), and NANOG (red). (b) Cartoon showing the ASE with amnion, embryonic disc, 
amniotic cavity, and PS-like phenotype. ASEs with PS-like phenotype were consistently 
observed on day 5. n = 18 independent experiments. (c) Carnegie stage 6 human embryo 
section showing the PS. Scale bars, 50 µm. 
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stage III, but not stage II, ASEs (Figure 3-11b). Instead, CDX2 is only expressed at the amniotic 
pole of stage II ASEs (Figure 3-11b), consistent with our finding in Chapter 2 that CDX2 ss an 
early human amnion marker92. We also tested whether FOXA2 - a marker for anterior PS and 
endoderm73,95 (Figure 3-11c) - was expressed in day 5 ASEs. However, FOXA2 expression was 
found absent in all ASEs (Figure 3-11d). Together, the molecular profile of day 5 ASEs suggests 
that stage I ASEs mimic peri-implantation, pre-PS amniotic sac, stage II ASEs resemble early PS  
 organization, and stage III ASEs model posterior PS patterning. 
 
Figure 3-10 ASEs exhibit molecular signature of progressive PS development. Confocal 
micrographs showing ASEs with different spatial patterning of BRACHYURY (BRA; red), 




Figure 3-11 ASEs resemble the posterior PS development. (a) Confocal micrographs showing 
anterior primitive streak (AntPS), posterior primitive streak (PostPS), and late primitive streak 
(LatePS) cells derived from hPSCs in 2D culture, stained for CDX2 (green). HOECHST (blue) 
counterstains the nuclei. (b) Confocal micrographs showing ASEs with different spatial 
patterning of BRACHYURY (BRA; red), and CDX2 (green) on day 5. (c) Confocal 
micrographs showing AntPS cells, stained for FOXA2 (red), and CDX2 (green). HOECHST 
(blue) counterstains the nuclei. (d) 3D rendering of a stage III ASE, stained for WGA (purple), 
FOXA2 (red), and CDX2 (green). HOECHST (blue) counterstains the nuclei. Scale bars in a, 
c, and d, 100 µm; in b, 50 µm.  
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Figure 3-12 The time-course of ASE development recapitulates the sequential order of posterior 
PS development. (a) Confocal micrographs showing time-dependent, stage-wise spatial 
patterning of BRA (red) and ECAD (green) in ASEs from day 3-5. Scale bars, 50 µm. (b) 
Cartoon summarizing the three chronological stages of ASE development that resembles PS 
progression from pre-PS stage to early and then posterior PS stages. 
 
 We next traced the dynamic BRA expression during ASE development. On day 3, only 
stage I ASEs are observed, with nuclear BRA evident only at the flattened amniotic side (Figure 
3-12a), consistent with our finding in Chapter II that BRA is an early human amnion marker, as 
well as another recent finding that BRA is expressed in nascent amnion in monkey embryos19. 
By day 4, nuclear BRA emerges in the embryonic disc in some, but not all (13/38), ASEs, 
suggesting asynchronous advances to stage II and PS initiation (Figure 3-12a). Stage III ASEs 
with BRA+, single emigrating cells are only evident on day 5 (Figure 3-12b). Notably, ECAD is 
concurrently lost in the BRA+, PS-like region of stages II and III ASEs (Figure 3-12a), 
consistent with a canonical EMT during PS development. Another EMT marker, SNAIL, was 
also expressed in cells emigrating from Stage III ASEs (data now shown). Together, these results 
show that ASEs can develop beyond the peri-implantation, pre-PS stage to model a progressive, 
posteriorizing PS development in vitro with in vivo-like sequential order (Figure 3-12b). 
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3.3.7 Spontaneous Patterning of BMP-SMAD Signaling in the Development of ASEs 
 During early embryogenesis, BMP-SMAD signaling plays a pivotal role in tissue 
specification and morphogenesis, as loss of Bmp2 or Smad5 results in defects in both amniotic 
and embryonic patterning in mice96,97. Recently, Sasaki et al. also reported the finding of BMP 
signaling patterning in amnion versus epiblast in post-implantation monkey embryos19. Thus, we 
next examined BMP-SMAD signaling during ASE development. Indeed, immunofluorescence 
analysis of phosphorylated SMAD1/5 (pSMAD1/5) - a downstream target and activator of BMP-
SMAD signaling - shows prominent nuclear pSMAD1/5 only at the amniotic pole of peri-
implantation (stage I) ASEs (Figure 3-13). Stage-dependent patterning of pSMAD1/5 was further 
observed (Figure 3-14), mirroring the progressive BRA expression patterning during ASE 
development (Figure 3-10, 3-12). Notably, nuclear pSMAD1/5 emerges in the embryonic disc 
prior to CDX2 (Figure 3-14), consistent with the recent finding that BMP-SMAD signaling 
activation precedes CDX2-mediated posterior PS development95. Importantly, BMP-SMAD 
signaling in the ASE is activated autonomously, as no exogenous BMP is supplemented to the 
culture. Together, these results provide direct evidence for autonomous, stage-dependent 
patterning of BMP-SMAD signaling during ASE development in vitro (Figure 3-15). 
 
Figure 3-13 Spontaneous patterning of BMP-SMAD signaling in pre-PS ASE. Confocal 
micrographs showing a peri-implantation, pre-PS ASE on day 5 stained with pSMAD1/5 






Figure 3-15 Cartoon summarizing spatial patterning of BMP-SMAD signaling in the ASE 
along its amnion-epiblast axis as well as along the medial-lateral axis of the embryonic disc. 
Color scale represents the intensity of BMP-SMAD signaling ranging from low to medium and 
high as indicated. 
  
 
   
Figure 3-14 Evolution of BMP-SMAD signaling patterning at PS development of the ASE. 
Confocal micrographs showing stage-wise spatial patterning of pSMAD1/5 (red) and CDX2 
(green) in ASEs on day 5. White arrow heads indicate pSMAD1/5+ cells in the embryonic disc 
of ASEs. Scale bar, 50 µm. 
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3.3.8 Discussion 
 Findings reported in this chapter demonstrate that hPSCs can self-organized in vitro and 
develop into a spontaneously patterned cystic structure modeling human amniotic sac 
development at implantation and early gastrulation. In particular, the in vitro model - ASE - 
could recapitulate the amnion-epiblast patterning and posterior PS development. However, the 
development of anterior PS was not observed in ASEs. Elongation of PS, which is a critical step 
for establishing the body axis, was not observed either. These results indicate that the current 
ASE can only partially model the fully complexity of human amniotic sac development. In 
addition, the current culture system generates ASEs only with low efficiency, which is a 
potential limiting factor for broader application of this in vitro model system. Development of 
more efficient and better controlled induction system for ASEs, for example, by providing an 
asymmetrically structured source of exogenous BMP ligand for inducing amniogenesis in only 
part of the cyst, would be of great interest in future studies.  
 So far, the canonical view in human embryology regards the amniotic sac development as a 
three-step process1: (1) epiblast polarization results in the formation of a transient cavity within 
the epiblast; (2) thinning of the roof of this cavity quickly opens the cavity and forms a so-called 
tropho-epiblastic cavity, the roof of which is formed by cytotrophoblasts and the bottom formed 
by the epiblast disc; (3) proliferation, differentiation, and migration of epiblast cells at the 
margins of the epiblast disc results in its upfolding, eventually enclosing a permanent cavity 
("the amniotic cavity") with the roof made of squamous cells destined to become the amnion. 
However, this paradigm is entirely drawn from interpretations of images of sectioned human and 
primate embryos, and different observations have also been reported by others in monkey 
embryos7,18.  
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 Strikingly, results reported here clearly demonstrate that the amniotic sac develops as a 
continuous epithelial cyst. That is, a cavity forms in cultured epiblast-like hPSCs, and no 
partially opened cyst is ever observed as the cyst expands and evolves to become the amniotic 
sac. During its expansion, one side of the cyst undergoes a distinct morphogenic 
cytodifferentiation and adopts a thin, squamous epithelial morphology; these squamous cells 
express markers of early human amnion. The other side of the cyst organizes into a thick, 
columnar epithelial disc that retains pluripotency markers. The single luminal cavity in the 
asymmetric cyst is continuously maintained throughout such development. Therefore, our 
findings significantly revise, if not refute, the current theory of the human amniotic sac 
development, and will open doors for future fundamental investigations of early human 
embryogenesis at implantation and gastrulation. 
 
3.4 Conclusions 
 This chapter shows that hPSCs can self-organize to model human amniotic sac development 
at implantation and beyond in a bio-inspired 3D culture system. Importantly, although long-
established textbook dogma advocates that human amniotic sac development involves an 
intermediate step in which the epiblast cyst is opened to the trophoblast, forming a tropho-
epiblastic cavity (d.p.f. 8)1,6, data in this chapter suggest otherwise - human amniotic sac 
develops as a continuous, intact epithelial cyst that constantly encloses the (pro-)amniotic cavity 
throughout implantation. Intriguingly, the ASE develops in the absence of other extraembryonic 
tissues and autonomously activates a patterned BMP-SMAD signaling, suggesting an unforeseen 
self-organizing capacity of pluripotent epiblast during human amniotic sac development. Besides 
new understandings of human development at implantation and early gastrulation, our findings 
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also unveil a new developmental potential and application of hPSCs. This work provides a new 
model - the ASE - for investigating the fundamentals of early human embryology, 
complementing scarce in vivo studies. It is envision that the ASE can also assist in studying 
human pregnancy and embryo toxicology, thereby advancing the field of human reproductive 
medicine.‡‡ 
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epithelial cells). I would also like to thank Dr. K. Sue O'Shea, Dr. Sundeep Kalantry, Dr. William Shawlot, Dr. 





Development of a Micro-engineered Human Amniotic Tissue Array 
for Reproductive Medicine 
4.1 Introduction 
 Development of amnion is a critical step for early human embryogenesis. It patterns the 
rudimentary morphology of human embryos and provides a paracrine source of BMP ligands, 
which could serve as important embryonic induction signals for the primordial germ cells19, 
epidermis98, and potentially the primitive streak94. Abnormalities in amnion development or 
formation could result in pregnancy failure or complications such as oligohydramnios99, 
premature rupture of amniotic membrane100,101, or amniotic band syndrome102. In Chapter II, I 
reported an in vitro culture system that can efficiently generate early human amnion-like tissues. 
However, such a system lacked the control over the size and location of hPSC-amnion cysts, and 
the gel bed has limited compatibility with large-scale fabrication, thereby limiting the use of such 
system for clinically relevant translational applications where high-content screening is preferred. 
Development of an in vitro high-throughput screening platform capable of assessing the effect of 
a wide range of genetic mutations, pharmaceutical products, or environmental toxicants/hazards 
on early human amnion development could have significant implications for reproductive 
medicine and public health (Figure 4-1).  
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 Conventionally, pharmaceutical industry relies on massively produced high-throughput 
screening systems for evaluating the efficacy of products on cultured cells or other biological 
samples103. Typically, those high-throughput screening platforms come with an array format due 
to its compatibility with large data yield and automatable data acquisition and analysis process. 
Most microarray-based high-throughput screening systems are commonly fabricated via mass 
manufacturing techniques, such as electrohydrodynamic jet printing104 or UV-mediated photo-
patterning105, on rigid substrates such as glass; while the robotic deposition of soft hydrogel 
materials106 is currently more limited to pioneering lab researches. However, the method 
established previously in Chapter II for inducing amniogenesis from hPSCs is not compatible 
with rigid substrates, posing a challenge for versatile generation of high-throughput screening 
platforms for assessing early human amnion development. 
 In this chapter, therefore, our first goal is to further explore the mechano-sensitivity of 
hPSC-amnion development based on findings made in Chapter II. To accomplish this, we will 
leverage the property of integrative mechanotransduction, which will be elaborated in Section 
4.3, and develop alternative strategies that can induce amniogenesis on rigid substrates that are 
compatible with standard, readily accessible microarray fabrication techniques. We will then 
 
Figure 4-1 Concept of a micro-engineered human amniotic tissue array as a high-throughput 
screening platform for reproductive medicine. 
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combine the new amniogenic method and a micro-engineered ECM array to demonstrate the 
proof of concept for a human amniotic tissue array platform that could be useful for high-
throughput screening for regenerative medicine in the future.   
  
4.2 Materials and Methods 
4.2.1 3D hPSC Amniogenesis Assay 
 In brief, cultured hPSCs were dissociated with Accutase (Sigma-Aldrich) at 37°C for 10 min 
before suspended in PBS as single cells. hPSCs were centrifuged before being resuspended in 
mTeSR1 containing 10 µM Y27632 (Tocris). hPSCs were plated as single cells at 30,000, 
20,000, 10,000, or 5,000 cells cm-2 onto a glass coverslip thinly coated with 1% GeltrexTM at 
room temperature for 1 h.  
 In some tests conducted on glass coverslip, culture medium was replenished at 24 h (on day 
1) after cell plating with fresh mTeSR1 without Y27632, and 4% (v:v) GeltrexTM was 
supplemented in the medium as previously described for 3D culture. Thereafter, mTeSR1 
medium was replenished daily, and 4% (v:v) GeltrexTM was supplemented daily till day 4, unless 
otherwise noted.  
 In other tests conducted on glass coverslip, the 3D ECM overlay was applied at 2 h after 
plating, and the culture medium was changed to fresh mTeSR1 containing 10 µM Y27632 and 
4% (v:v) GeltrexTM. At 24 h after plating, culture medium was replenished with mTeSR1 without 
Y27632, and 4% (v:v) GeltrexTM was supplemented in the medium. Thereafter, mTeSR1 medium 
was replenished daily, and 4% (v:v) GeltrexTM was supplemented daily till day 4.  
 In tests conducted on the micro-engineered ECM array, cells were plated at 40,000 cm-2 
onto the micro-engineered ECM array in mTeSR1 containing 10 µM Y27632. The 3D ECM 
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overlay was applied 2 h after plating and the culture medium was changed to mTeSR1 
containing 10 µM Y27632 and 4% (v:v) GeltrexTM. At 24 h, culture medium was replenished 
with mTeSR1 without Y27632, and 4% (v:v) GeltrexTM was supplemented in the medium. 
Thereafter, mTeSR1 medium was replenished daily, and 4% (v:v) GeltrexTM was supplemented 
daily till day 3.  
4.2.2 Fabrication of Micro-engineered ECM Arrays 
 The micro-engineered ECM array containing basement membrane matrix protein (GeltrexTM) 
was generated using a standard micro-contact printing protocol as described elsewhere before107. 
In brief, to prepare the substrate for the ECM array, a glass coverslip was spin-coated with a thin 
layer of PDMS (base:curing agent ratio as 10:1) at 2,000 rpm for 40 s before being cured at 70°C 
for overnight. PDMS stamps containing regularly patterned circular protrusive features of area 
3,600 µm2 (diameter ~ 67 µm) were generated using standard soft lithography as described 
elsewhere before71. To "ink" the stamp with ECM proteins, 1% GeltrexTM solution was deposited 
onto the surface of the stamp carrying the desired patterns before being incubated in 4°C for 
overnight. The PDMS-coated coverslip was treated by UV Ozone for 7 min before being printed 
with the GeltrexTM-coated stamps. The protein transfer was accomplished upon peeling off the 
stamp after its conformal contact with the coverslip. The printed ECM array substrate was 
sterilized with 70% ethanol for 1 min before being blocked for 30 min using 0.2% (w:v) Pluronic 
F127 to prevent cell attachment on un-printed area. The ECM array substrate was then rinsed by 





4.3 An Integrative Mechanotransduction Pathway for hPSC Amniogenesis 
 Cells are active "sensors" of not only their biochemical environment but also the 
biomechanical niche surrounding them42,108-110. Through past years, an important concept that I 
named "integrative mechanotransduction" has emerged as a general property of cells that are 
sensitive to microenvironmental mechanical cues24. Mounting experimental data obtained from 
various types of cells, including hPSCs24, suggest that a wide range of upstream mechanical 
signals, such as matrix rigidity111-113, substrate topography114-116, cell/colony area and 
spreading89,117,118, cell geometry/shape and local curvature119-122, cell contractility70, etc., could 
eventually induce similar differentiation phenotypes from a certain cell type (Figure 4-2), via a 
shared core signaling transduction components24, including actin cytoskeleton, SMAD, and 
YAP/TAZ, etc., that integrates those upstream mechanical signals to elicit common downstream 
differentiation inductions. Herein, as an example case that supports the notion of the integrative 
mechanotransduction, we will first briefly review classic findings in past decade on the 
mechanobiology of human mesenchymal stem cells (hMSCs)24. We will then set to examine 
 
Figure 4-2 Concept of integrative mechanotransduction, which integrates multiple upstream 
mechanical signals to elicit similar differentiation of stem cells. 
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whether the amniogenesis by hPSCs can be elicited by other mechanical factors in an integrative 
mechanotransductive manner. Such knowledge could help develop new, versatile amniogenic 
methods that are compatible with a larger spectrum of substrates and bio-manufacturing systems. 
4.3.1 Integrative Mechanotransduction: a Lesson from hMSCs 
 For over a decade, the mechanobiology and mechanotransduction of hMSCs have been 
extensively studied and have provided extraordinary examples and paradigms for understanding 
the control of stem cell fate via regulating extracellular insoluble biophysical signals24,123.  
 As a measurement of the resistance to deformation, mechanical stiffness of the embryo 
varies in space and over time during development, generating a distinct pattern of tissue stiffness 
throughout the human body124,125. The interesting idea of using tissue-mimicking matrix stiffness 
to regulate stem cell differentiation can be originated back to the seminal work by Engler et al., 
which demonstrated that brain-like soft polyacrylamide (PA) hydrogel substrates enhanced 
neurogenesis of human mesenchymal stem cells (hMSCs), while PA substrates with muscle- and 
bone-mimicking stiffness promoted cardiogenesis and osteogenesis, respectively124. Using 
microfabricated elastomeric polydimethylsiloxane (PDMS) micropost arrays with different post 
spring constants - a physical analogy of varying substrate stiffness, Fu et al. also demonstrated 
that substrate stiffness could serve as an extracellular switch to direct hMSC differentiation 
between osteogenesis and adipogenesis70. In recent studies, dynamic substrate stiffening was 
shown to either switch hMSCs from adipogenesis to osteogenesis126 or promote their cardiogenic 
differentiation127.  
  In addition, researchers have also developed different bioengineering strategies to modulate 
micro/nanoscale topography of cellular microenvironment, in order to control the lineage 
differentiation of hMSCs. A notable study by Dalby et al. showed that synthetic substrates with 
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disordered nanoscale topographical features enhanced osteogenesis of hMSCs128. Substrates 
composed of nanotubes were also applied for hMSC culture, with results demonstrating that 
hMSC osteogenesis was promoted on nanotubes with greater diameters129.  
 Cell shape is another important cell property dynamically regulated during embryonic 
development and has been leveraged to regulate stem cell fate determination as well. Indeed, 
numerous studies have supported cell shape as a potent biophysical regulator of hMSC fate and 
function. In one of the earliest studies, McBeath et al. applied micro-contact printing to coat flat 
PDMS surfaces with distinct patterns of adhesive ECM islands and reported that single hMSCs 
confined to small ECM islands selectively underwent adipogenesis, whereas single hMSCs on 
large ECM islands were biased toward osteogenesis120. More recent studies further revealed that 
in addition to cell shape, cell geometry could also influence hMSC differentiation. hMSCs of 
elongated morphology preferred osteogenesis, whereas those with a low aspect ratio morphology 
were biased toward adipogenesis121. Similarly, Lee et al. observed on soft PA substrates that a 
confined cell shape would promote hMSC adipogenesis, whereas a spread, branching cell 
morphology promoted hMSC neurogenic differentiation130.  
 Together, above findings clearly suggest that multiple environmental physical cues, e.g., 
matrix rigidity, substrate topography, and cell morphology, can exert comparable regulatory 
effects on hMSC lineage specification towards osteogenesis, adipogenesis, or neurogenesis. 
However, those findings above per se do not clearly indicate whether different upstream physical 
cues are acting in parallel with each other or they are cross-talking to each other and eventually 
forming an "integrative" signal transduction. In other words, despite it is now evident that cells 
can respond to multiple environmental physical cues and translate them into similar cell fate 
specification instructions as schematized in Figure 4-2, it remains unclear in regard to the 
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identity of the cell property that truly "integrates" those signals and thereby initiates an 
integrative mechanotransduction.   
 Interestingly, those data above do manifest an emerging trend. Specifically, neurogenic 
environmental cues such as soft substrates and micro/nano-topographical surfaces typically 
induce small cell spreading area and slender, elongated cell morphology; osteogenic 
environmental cues such as rigid substrate and low cell confinement usually elicit large cell 
spreading area and plaque-like cell morphology; adipogenic environmental cues such as soft 
substrate and high cell confinement commonly result in limited cell spreading and small-droplet-
like cell morphology. This trend implies that "cell spreading" seems to be a biological 
"integrator" commonly regulated by different upstream mechanical cues, suggesting a further 
developed view into the concept of the integrative mechanotransduction (Figure 4-3). 
 
Figure 4-3 The further developed concept of integrative mechanotransduction based on 
previous findings from hMSCs. This schematic highlights the "integrative nature" of a 
mechanotransduction pathway that integrates multiple upstream mechanical signals via a 
common cell property - cell spreading - to elicit similar differentiation of stem cells. 
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 Importantly, in order to further test whether cell spreading is the bona fide integrator of 
upstream environmental mechanical cues, researchers have developed ingenious biomaterials 
systems that can independently manipulate multiple extracellular and cellular mechanical 
properties including cell spreading. For example, Khetan et al. developed a 3D hyaluronic acid-
based hydrogel which can be used to independently adjust the stiffness and degradability of the 
matrix environment surrounding the encapsulated hMSCs118. Interestingly, they found that by 
rendering a soft hydrogel degradable by cell-surface-localized matrix proteases, cultured hMSCs 
exhibited spread morphology and were predisposed towards osteogenesis instead of adipogenesis; 
in contrast, a non-degradable hydrogel, regardless of its stiffness, confines hMSCs and limits cell 
spreading, eventually resulting in adipogenesis rather than osteogenesis even when a stiff 
hydrogel was used. These results, together the other results discussed earlier, suggest that fully 
deployed cell spreading, instead of high matrix rigidity, is the common cell property that 
promotes hMSC osteogenesis; while confined cell spreading, rather than low matrix rigidity, is 
the common cell property that induces hMSC adipogenesis. These data support the concept that I 
herein developed for the "integrative mechanotransduction" (Figure 4-3), which has not yet been 
explored in hPSCs24. Further understanding of the integrative mechanotransduction in hPSCs 
could enable more versatile bioengineering strategies for inducing desired cell fates.  
4.3.2 Substrate Rigidity, Cell Cluster Size, and Cell Spreading Share an Integrative 
Mechanotransduction Pathway for hPSC Amniogenesis 
 Inspired by the concept of the integrative mechanotransduction, we next set to explore 
whether other mechanical factors, such as cell spreading/area, can induce amniogenesis from 
hPSCs on rigid substrates to a level that is comparable to that in the Gel-3D culture system. 
Indeed, when cultured on rigid substrate (glass) and soft substrate (thick gel bed), respectively, 
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for just 24 h without adding 3D ECM overlay, hPSC clusters exhibit significantly different sizes. 
Specifically, hPSCs clusters on rigid substrate contain larger number of cells and also appear to 
be significantly larger in size/projected area (Figure 4-4a,b,c). Individual cells within the cluster 
on a rigid substrate also adopt more spread morphology and larger area (Figure 4-4a,d). In 
contrast, hPSC clusters formed on soft gel bed are smaller in size/projected area and also contain 
fewer cells per cluster (Figure 4-4a,b,c). The average area for individual cells is also notably 
smaller on the gel bed (Figure 4-4a,d). Together, these results suggest that the softness of Gel-3D 
amniogenic niche exerts concurrent restriction on cell cluster size, cell size, and cell spreading.  
 
Figure 4-4 Soft gel bed restricts the size of cell clusters as well as individual cells. (a) 
Confocal micrographs showing the immunostaining of ECAD (green) and HOECHST (blue) 
in hPSCs cultured on glass coverslip (left) and gel bed (right) 24 h after plating. Scale bar, 50 
µm. (b-d) Statistical results of cell number in each cluster (b), cell cluster size (c), and average 
cell size (cell cluster size / cell number per cluster) (d) for hPSCs cultured on glass and gel 
bed, respectively. Box charts: box, 25-75%; line-in-box: median; wiskers: 1-99%. P-values 




 We next set to examine whether decrease in cell plating density, which effectively reduces 
the size of hPSC clusters in culture, could enhance the development of amniotic tissue from 
hPSCs on rigid glass substrate (Glass-3D condition). Specifically, the cell plating density was 
reduced from previously 30,000 cm-2 to 20,000, 10,000, and 5,000 cm-2, respectively. 
Interestingly, modest differentiation of TFAP2A+, squamous, amnion-like cysts was observed in 
Glass-3D condition when the cell plating density, and thereby the cell cluster size, is at the lower 
end (Figure 4-5). This result suggests that it is indeed possible to elicit hPSC amniogenesis on a 
rigid substrate by mimicking the restricting effect of soft gel bed on cell cluster sizes, consistent 
with the idea of integrative mechanotransduction. Specifically, above results indicate that cell 
cluster size/projected area and cell-cell interaction, both of which are affected by the cell plating 
density, might be involved in the integrative mechanotransduction for hPSC amniogenesis.  
 
Figure 4-5 Reducing cell plating density in Glass-3D condition modestly increases the hPSC-
amnion development. (a) Confocal micrographs showing immunostaining of HOECHST 
(blue), WGA (red), and amniotic marker TFAP2A (green) in hPSCs cultured in Glass-3D 
condition under different cell plating density as indicated at day 3. Scale bar, 50 µm. (b) 
Statistical results showing the percentage of TFAP2A+ squamous cysts under each condition 
as indicated. Data were plotted as mean ± s.e.m. P-values were calculated using unpaired, two-
sided Student's t-test. **: P < 0.01. 
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 Results shown in Figure 4-4a&d also suggest that in Gel-3D condition, soft gel bed restricts 
cell spreading and cell area, which, together with 3D ECM environment, might further induce 
amniogenesis from hPSCs. In order to test whether restricted cell spreading, in combination with 
3D culture, is sufficient to mimic the amniogenic property of Gel-3D condition on a rigid 
substrate, we plated hPSCs on glass substrate and supplemented the 3D ECM overlay 2 h after 
plating, before cell spreading was fully deployed. Compared with previous tests under Glass-3D 
conditions, wherein the ECM overlay was provided 24 h after cell plating, supplementation of 
3D ECM overlay shortly after cell plating significantly increases the development of TFAP2A+, 
squamous amnion-like cysts under all conditions tested (Figure 4-6a). This result demonstrates 
that the combination of 3D ECM environment and limited cell spreading is sufficient to induce 
efficient hPSC amniogenesis on a rigid substrate, likely due to the recapitulation of the effect of 
  
Figure 4-6 Introducing 3D ECM overlay shortly after cell attachment, before full deployment 
of cell spreading, significantly increases the development of amnion-like cysts. (a) Statistical 
results showing the percentage of TFAP2A+ squamous cysts under different conditions as 
indicated at day 3. 3D ECM overlay was applied either at 24 h or at 2 h after plating. When it 
was applied 2 h after plating, 10 µM Y27632 was also supplemented in the medium and 
remained till the next change of medium at 24 h. (b) Schematic illustrating the concept of the 




Gel-3D niche on constraining cell spreading by substrate softness. Above findings also support 
the existence of an integrative mechanotransduction pathway that controls the development of 
amnion-like tissues from hPSCs via integrating multiple upstream mechanical signals including 
matrix rigidity, cell density, ECM dimensionality, and cell spreading to make a common fate 
decision, with cell spreading and cell-cell interaction probably acting as the "integrator" (Figure 
4-6b). In complementary to the Gel-3D culture developed in Chapter II, results reported in this 
chapter have established an alternative method that can be applied on rigid substrates to induce 
amniogenic differentiation from hPSCs.  
 
4.4 Development of a Micro-engineered Human Amniotic Tissue Array 
 As a standard and easily accessible bioengineering technique for micro-scale patterning, 
micro-contact printing has enabled rapid prototyping of microarray-based experimental 
platforms. By leveraging micron-contact printing, we can conveniently create large-scale arrays 
 
Figure 4-7 Micro-engineered human amniotic tissue array from hPSCs. (a) Confocal 
micrograph showing the staining of LAMININ (red) in the micro-contact printed array of 
GeltrexTM. Scale bar, 100 µm. (b) Confocal micrograph showing the staining of amniotic 
marker TFAP2A (green) in the cysts formed on the GeltrexTM ECM array. Scale bar, 100 µm. 
(c) Confocal micrographs showing the staining of HOECHT (blue), NANOG (green), 
TFAP2A (red), and WGA (purple) in a representative cyst cultured on the micro-engineered 
ECM array at day 3. Scale bar, 30 µm. (d) Confocal micrographs showing the staining of 
HOECHT (blue), GATA3 (green), TFAP2B (red), and WGA (purple) in a representative cyst 
cultured on the micro-engineered ECM array at day 3. Scale bar, 30 µm.  
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of ECM proteins, herein 1% GeltrexTM (Figure 4-7a), on a glass coverslip pre-coated with a thin 
layer of PDMS.  
 By using the modified Glass-3D culture condition, wherein 3D ECM overlay was 
supplemented shortly after cell plating, we have conducted hPSC amniogenesis assay on the 
micro-contact printed ECM arrays and successfully induced the development of squamous cystic 
structures expressing TFAP2A (Figure 4-7b), an early human amniotic marker we identified in 
Chapter II. As expected, those cysts only grew on the pre-defined microarrays (Figure 4-7b), 
which is a prerequisite for this system to be used as a high-throughput screening system in 
future . Those cystic structures also showed expression of TFAP2B and GATA3, which are 
additional hPSC-amnion markers; expression of pluripotency marker NANOG was lost (Figure 
4-7c,d) in those squamous cysts. These results demonstrated the proof of concept for the 
development of a human amniotic tissue array in vitro.  
 
4.5 Conclusions  
 In conclusion, this chapter has expanded our previous understanding of the 
mechanosensitive nature of hPSC-amnion development and leveraged such new knowledge to 
demonstrate the proof of concept for a micro-engineered human amniotic tissue array that is 
derived from cultured hPSCs in vitro. Specifically, findings reported in this chapter indicated an 
integrative mechanotransduction pathway that integrates diverse upstream mechanical signals, 
e.g., matrix rigidity, cell density, and cell spreading/area, to induce hPSC-amnion development. 
Such notion could enable the application of a wider spectrum of substrates and culture conditions 
in the bio-manufacturing of hPSC-amnion in future. It also achieves the successful combination 
of micro-engineered ECM array with hPSC-amnion development, thereby generating a human 
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amniotic tissue array that can potentially be applied for reproductive medicine in the future. At 
this moment, the work described in this chapter is still preliminary for the translational 
application it aims at. The molecular basis for the newly found integrative mechanotransduction 
underlying hPSC amniogenesis also needs to be studied in the future. The outlook of this work 
will be discussed in Chapter 5.‡‡‡   
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Conclusions and Future Work 
 
5.1 Summary  
 Implantation is a critical process that initiates the intrauterine development of a human 
embryo. Abnormalities during implantation could potentially cause pregnancy failure or birth 
defects. A better understanding of peri-implantation human embryogenesis is of fundamental and 
clinical importance, but has been hindered by the inaccessibility to in vivo samples and the lack 
of in vitro methods. In this dissertation, I endeavored to fill this gap in knowledge and 
technology about early human embryonic development, by developing hPSC-derived in vitro 
culture models that mimic peri-implantation development of the human amnion and amniotic sac. 
These in vitro models will provide researchers with easily accessible, scalable, and malleable 
tools for studying peri-implantation human developmental events that were barely approachable 
before.  
 By using an hPSC-based in vitro model, we unveiled the previously unrecognized ability of 
hPSCs to respond to extracellular mechanical cues to recapitulate the morphological and cell fate 
characteristics of early human amnion development during implantation. In particular, we 
demonstrate that human amnion-like tissue can develop from hPSCs in the absence of additional 
inductive signals from maternal and other extraembryonic tissues, thereby challenging traditional 
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dogma about the requirement of maternal/trophoblastic paracrine signals for amniogenesis. 
Interestingly, this dissertation identified a unique sensitivity of hPSC amniogenesis to the 
physical property of the matrix. By simply modulating the thickness of the matrix bed, which 
tunes it apparent mechanical stiffness, it can toggle hPSCs between amniogenic differentiation 
and self-renewing expansion. This finding indicates that physical cues in the peri-implantation 
niche might play an important role in eliciting amniogenesis from an otherwise continuously 
self-renewing population of epiblast.  
 The work in this dissertation also demonstrated a self-sustaining mechanism underlying 
human amniogenesis, which occurs via autocrine BMP-SMAD signaling. Specifically, the 
amniogenic differentiation of hPSCs activates endogenous BMP ligand production, which is in 
turn required for sustaining the progression of amniogenesis. This finding suggests that the 
amnion might serve as a source of BMP ligands and a paracrine BMP signaling center for the 
induction of additional extraembryonic tissues in the early human embryo. Indeed, such notion is 
supported by recent finding in cynomolgus monkey embryos, which highlighted a potential role 
of nascent amnion in inducing PGC differentiation via paracrine BMP signaling19.  
 By demonstrating the hPSC-derived asymmetric cystic structure that resembles early human 
amniotic sac, the data in this dissertation highlighted a previously unappreciated self-patterning 
nature of human amniotic sac development. In particular, we showed that bipolar amnion-
epiblast patterning can be established within an intact lumenal cyst via concurrent differential 
morphogenic cytodifferentiation, which suggests a developmental paradigm different from the 
long-established textbook dogma put forward by Luckett6 in 1975. Indeed, under no 
circumstances did we observe opening of and re-sealing of the cyst as required in the Luckett 
model. The patterning of amnion-epiblast axis is also demonstrated to be correlated with a 
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similarly patterned BMP-SMAD signaling, indicating an important role of intrinsic signal 
patterning/gradient for the development of human amniotic sac. Indeed, such bipolar patterning 
of BMP signaling along the amnion-epiblast axis was recently confirmed in post-implantation 
cynomolgus monkey embryos19.  
 As a final aim, I also endeavored to extend our newly developed in vitro model for peri-
implantation human amniogenesis to a translationally applicable format that is compatible with 
large-scale screening for reproductive medicine. To achieve this goal, we first examined cellular 
properties that are possibly required for the amniogenic differentiation from hPSCs. Importantly, 
we identified cell spreading and cell density-dependent cell-cell interactions as two possible 
integrators of  an integrative mechanotransduction pathway that underlies the amnion-like tissue 
development from hPSCs. This finding significantly broadened the scope of bioengineering 
strategies that can be used to induce hPSC amniogenesis. Leveraging such findings, we 
demonstrated the proof of concept for a micro-engineered hPSC-based human amniotic tissue 
array, which could potentially open new avenues for reproductive medicine in the future. 
 In conclusion, I describe in this dissertation the first hPSC-derived in vitro models for 
studying and understanding important peri-implantation human developmental events. The 
findings reported in this dissertation provide new insights into early human developmental 
biology and bring opportunities for future exploration of an uncharted territory - peri-
implantation human embryology. 
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5.2 Future Work and Perspectives 
5.2.1 Developmental Biology of hPSC-Amnion Development and Human Amniogenesis 
 Serving as an efficient in vitro model, hPSC-amnion can be utilized in the future for 
studying the developmental biology of human amniogenesis. Although in this dissertation we 
have extensively demonstrated the molecular similarity between hPSC-amnion in vitro and early 
human amniotic tissue in vivo, we were limited by currently available human amniotic tissue 
transcriptome data sets which were acquired only for later pregnancy. An important future goal 
is therefore to compare the molecular profile of hPSC-amnion to that of peri-implantation non-
human primate amnion, since human amniotic tissues at corresponding stage are likely not 
available for ethical reasons. Despite the fact that such primate data sets do not exist in publicly 
available database at this moment, recent studies by the Saitou group suggest that it might be 
possible, although technically challenging, to isolate peri-/post-implantation monkey amniotic 
cells and subject them to single-cell RNA-seq analysis in the near future19. By comparing the in 
vitro hPSC-amnion model with in vivo data set, it could not only ultimately and definitively 
validate the legitimacy of our in vitro model, but also reveal more information on the 
spatiotemporal connection between hPSC-amnion development and the in vivo human 
amniogenesis. For example, by comparing the transcriptome of hPSC-amnion at different time 
points along the 5-day developmental course with that of monkey amniotic cells at different 
developmental stages, e.g. from E11 - E15, we might be able to match the in vitro hPSC-amnion 
development with distinct stages during in vivo amnion development.  
 In addition, our RNA-seq data indicate an enrichment of HOX genes, e.g., HOXB2 and 
HOXB3, in hPSC-amnion. Given the well-established role of HOX genes in the specification of 
posterior embryonic patterning131,132, this result suggests that hPSC-amnion might have adopted 
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a posterior amniotic fate. Therefore, if it becomes technically feasible in the future to isolate 
monkey amniotic cells from anterior and posterior regions, respectively, and then subject them to 
single-cell RNA-seq analysis, it will be of importance to investigate whether the hPSC-amnion in 
vitro is more similar to anterior or posterior amniotic cells in vivo, thereby providing new 
insights regarding whether hPSC-amnion has already undergone regional specification in the 
current culture system.  
 Extending from the above rationale, it will also be of importance to examine whether the 
composition of the currently used culture medium - mTeSR1 - might have certain effects on 
specifying the regional identity of hPSC-amnion generated in vitro. In fact, mTeSR1 contains 
lithium chloride (LiCl)133, a chemical that inhibits GSK3β and thereby could indirectly activate 
β-CATENIN/WNT signaling pathway that is known to be involved in certain posteriorizing 
embryonic patterning events134. In light of this consideration, it is tempting to speculate that the 
existence of LiCl in the current culture system might be a reason that causes the appearance of 
HOX genes in hPSC-amnion. In order to test whether certain components of mTeSR1 medium 
have important roles in the morphogenesis, differentiation, and/or possibly regionalization of 
hPSC-amnion, I plan to take advantage of a different medium called Essential 8 (E8)135, which is 
a formula simplified from mTeSR1 and contains only 8 essential factors of mTeSR1. The E8 
medium provides an easily accessible chemical platform from which I could reconstruct a 
"reduced" formula of mTeSR1, which can be designed to lack certain factors, for example LiCl, 
that are seen in standard mTeSR1. By using such a defined and "reduced" formula, I will 
examine whether withdrawing certain factors from standard mTeSR1 could cause a significant 
change in hPSC-amnion's molecular or morphological identities. This work could potentially 
shed light on the biochemical signaling that controls hPSC-amnion fate and morphology. If 
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successful, this work could also yield sufficient knowledge so that we can compose customized 
cell culture medium for inducing amnion-like tissues of possibly different regional identities. 
Generation of potentially regionalized human amniotic tissues will not only help advance our 
understanding of early human amniogenesis, but also could provide a novel platform for 
studying the developmental origin of other embryonic and extraembryonic tissues that are related 
to amnion. For example, Sasaki et al. recently found that PGCs, the precursors of germ cells that 
develop in the embryo proper, originate from posterior amniotic epithelium in cynomolgus 
monkey embryos19. Therefore, I am interested in exploring the possibility to derive human PGC-
like cells from hPSC-derived posterior amnion-like tissues in the future. 
 Nevertheless, there are also other possible explanations for the enrichment of 
posteriorization-associated HOX genes in hPSC-amnion. For example, given that BMP signaling 
has also been known involved in posterior embryonic regionalization in mice136, and that 
endogenous BMP signaling has been found as a prominent inductive signal during hPSC-amnion 
development in this dissertation, it is possible that the appearance of those HOX genes is 
attributed to such BMP signaling, instead of the existence of LiCl in the culture medium. Indeed, 
in the recent study by Sasaki et al., BMP4 is found first expressed throughout the entire early 
monkey amnion and then becomes more restricted at the posterior amniotic epithelium during 
further development19. This observation implies that the BMP4 signaling per se might have 
certain inductive effect for posterior tissue specification. Therefore, it is also worthy of studying 
in the future whether BMP signaling is truly the driving force for posterior amniotic tissue 
specification, or it is just a concurrent signaling that supports, but does not necessarily causes, 
the posteriorization of early primate amnion.   
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 Notably, the hPSC-amnion described in this dissertation likely represents only the early 
stage of human amnion development. Considering that human amniotic membrane will later on 
recruit extraembryonic mesenchymal cells during further development, and that it will eventually 
fuse with the chorion, it will be of interest in the future to attempt to generate more matured and 
sophisticated human amnion-like tissues in vitro, by either modifying the culture medium or 
supplementing mesenchymal cells into the current culture system to build a co-culture platform. 
These efforts could lead to broader understanding of amniotic tissue development in humans.          
5.2.2 Cell Biology of the hPSC-Amnion  
 Besides examining the developmental biology of hPSC-amnion, I am also interested in 
investigating the unique cell biological properties of hPSC-amnion. Notably, hPSC-amnion as 
well as in vivo human amnion adopt a unique squamous epithelial morphology, which is 
drastically different from the columnar epithelial morphology seen in undifferentiated hPSCs and 
in vivo epiblast cells. The biological meaning of such a squamous morphology is an intriguing 
fundamental question that needs to be answer in the future.  
 Specifically, considering that amnion, but not epiblast, is the main source for amniotic fluid 
and is responsible for regulating the volume and pressure inside the amniotic cavity/sac as well 
as other physiochemical parameters like the ion concentration, pH value, etc. in the amniotic 
fluid, it is tempting to speculate that such differences in functions between amnion and epiblast 
might root in their differences in epithelial cell characteristics. For example, claudins - a family 
of proteins localized at tight-junctions that seal an epithelial sheet - are known to have important 
roles in controlling ion/fluid transportation during embryonic epithelial structure morphogenesis 
(e.g., gut lumen formation in zebrafish137). Interestingly, the RNA-seq data set reported in this 
dissertation demonstrated that compared with undifferentiated hPSCs, hPSC-amnion 
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significantly up-regulates the mRNA levels for CLDN4 and CLDN10 - transcripts encoding two 
distinct members of the CLAUDIN family, suggesting a remodeled tight-junction protein 
community in hPSC-amnion. The next step is to study whether there is a functional connection 
between CLDN4, CLDN10 and amnion-specific functions such as ion/fluid transportation. 
Furthermore, by using the RNA-seq data set provided in this dissertation, a comprehensive 
transcriptomic and functional ontology analysis in regard to cell polarity-associated functional 
terms for hPSC-amnion might provide deeper insights into the regulatory mechanisms 
underlying amnion-specific epithelial functions.  
 During embryonic development, cells constantly "talk" to each other through secreted 
molecules and elements. Given that the amnion and epiblast enclose the same single fluid-filled 
cavity - the amniotic cavity, they are poised for constant cross-talk via paracrine signaling. 
Therefore, it is tempting to ask how amnion and epiblast cross-talk to each other, and to 
speculate whether the amnion and epiblast have different cell secretion and whether such a 
difference could play an important role in dictating or sustaining the bipolar amnion-epiblast 
patterning, possibly through unknown feedback signaling loops. Following this line of thinking, 
it is important to study in the future the secretome of both hPSC-amnion and undifferentiated 
hPSCs. Such a study could deepen our understanding of the specific and possibly distinct roles 
played by amnion and epiblast, respectively, in the amniotic sac morphogenesis, lending us the 
answer to the question - "amnion and epiblast, are they friends or foes?".  
 In addition, it will also be of interest to investigate the molecular determinants of the 
squamous epithelial morphology of amnion. In this dissertation, we found that hPSC-amnion 
activates a unique subset of EMT-related transcription factors (EMT-TFs), namely BRA, SLUG, 
but not SNAIL, while undergoing a columnar-to-squamous epithelial morphological transition 
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(Figures 2-10, 2-11, and 2-12). Such co-existence of ECAD+ epithelial phenotype and EMT-TFs 
in the squamous amnion-like tissue appears paradoxical, because EMT-TFs such as BRA and 
SLUG have been demonstrated as transcriptional repressors of ECAD138; nevertheless, no down-
regulation of ECAD at either mRNA or protein level did we observe in the hPSC-amnion 
development. In contrast, expressions of BRA, SLUG, as well as SNAIL were observed in PS-
cell development, with concurrent transformation from hPSC-associated epithelial phenotype to 
PS-cell-associated mesenchymal phenotype. Taken together, these observations suggest that 
EMT-TFs might have more complicated interactions with epithelial tissue regulation than that is 
conventionally regarded. Specifically, each EMT-TFs might have its distinct role in regulating 
the epithelial phenotype. Therefore, it will be of importance in the future to dissect the specific 
role of EMT-TFs like SLUG and SNAIL, respectively, in hPSC-amnion development. By 
leveraging CRISPR/CAS9139,140 - an efficient gene-editing system that has been rapidly adapted 
among life science research community, we can generate genetically modified hPSC lines in 
which SLUG or SNAIL is deleted. Using these knockout hPSC lines, we can examine the role of 
each of those EMT-TFs in hPSC-amnion morphogenesis. 
 In this dissertation, our data demonstrated significant up-regulation of a cohort of 
transcription factors during the development of hPSC-amnion. This cohort of transcription 
factors include quite a few well-known targets of BMP signaling, e.g., HAND1/2, MSX1/2, 
DLX5/6. However, it remains unclear whether these transcription factors are bona fide molecular 
determinants of the amniotic cell fate or they are merely mediators of a more fundamental 
regulatory circuitry that specifies the amniogenesis. Given the broad implication of these BMP 
targets in a variety of developmental processes such as neural crest development141 and heart 
development142, it is tempting to speculate that they might not be the direct determinants for the 
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amniotic cell fate. Therefore, it remains an important question to study that whether other 
transcription factors (e.g., TFAP2A, TFAP2B) that are not direct downstream targets of BMP 
signaling could be the determinants of the amniotic fate. In the end, it will be of interest to 
identify a minimal set of transcription factors that are capable of reprogramming the 
transcriptional circuitry of adult human somatic cells to that of amniotic cells; these induced or 
directly reprogrammed human amniotic cells will no longer require hPSCs as source cells and 
eliminate the need of a 3D matrix environment for derivation, thereby greatly simplifying the 
bio-fabrication process and facilitate their clinical applications.        
5.2.3 Mechanobiology of hPSC-Amnion Development 
 In this dissertation, we clearly demonstrated that the development of hPSC-amnion is 
regulated by microenvironmental physical factors - namely, the matrix rigidity and ECM 
dimensionality - in a biochemical context permissive for hPSC self-renewal. This finding reveals 
a previously unrecognized mechano-sensitive nature of hPSCs and suggests a potential important 
role of mechanotransduction for early human embryonic inductions. To further explore the scope 
of the mechano-sensitivity of hPSC-amnion development, we examined the effect of other 
physical factors and demonstrated an integrative mechanotransduction pathway that allow cells 
to integrate matrix rigidity, ECM dimensionality, cell density, and cell spreading to induce hPSC 
amniogenesis. These findings have not only broadened the bioengineering strategies for 
generating hPSC-amnion in vitro, but also provided new insights into the mechanobiology and 
mechanotransduction underlying the amniotic cell fate specification.  
 Notably, the prominent sensitivity of hPSC-amnion development to matrix rigidity suggests 
a potential role for cell-matrix adhesions in the amniogenic mechanotransduction. Interestingly, 
our RNA-seq analysis results indicated a significant increase in ITGA8 and ITGB6 in hPSC-
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amnion, putting integrins - a transmembrane protein family that plays a pivotal role in meditating 
cell-ECM adhesions - under my focus. Integrins have long been known for its capability of 
responding to extracellular mechanical cues and thus being at the very upstream of cellular 
mechanotransduction143. I will briefly review our current understanding of integrin-mediated 
mechanotransduction in the next a few paragraphs144.   
 Integrins are heterodimeric transmembrane proteins composed of an α and a β subunit. 
Currently, there are 24 known integrin heterodimers constituted by different combinations of 18 
α and 8 β subunits145-148. hESCs express a broad range of integrins including α1, α2, α3, α5, α6, α7, 
α11, αV, αE, and β1, β2, β3, β5, β6 integrins. hiPSCs are also reported to express mainly α5, α6, αV, 
β1, and β5 integrins, with variations among different hiPSC lines149-151. The first step adherent 
 
Figure 5-1 Schematic summarizing a few hypothetical mechanotransduction pathways 
underlying the mechano-sensitive hPSC amniogenesis.  
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cells take to probe the surrounding ECM is mediated by the "inside-out" and "outside-in" 
bidirectional regulation of integrin-ligand binding152-154. Specifically, initial binding of integrin 
to adhesive molecules initiates clustering of intracellular adaptor proteins including talin,  
which in turn binds the cytoplasmic domain of integrin, resulting in a conformational change of 
integrin's extracellular domain and its heightened affinity to corresponding ECM ligands. Firm 
binding of integrin to ECM ligand in turn activates clustering of integrins through their 
intracellular domains and further recruits adaptor and signaling proteins to adhesion sites. Key 
molecular players in the early stage of integrin-mediated cell-ECM adhesion (also known as 
"focal adhesion", or FA) include adaptor proteins talin, vinculin, and paxillin as well as tyrosine 
kinases such as focal adhesion kinase (FAK) and Src family kinases155,156 (Figure 5-1). 
 Through adaptor proteins such as talin and vinculin157, FAs physically connect to actin 
cytoskeleton (CSK) which is interwoven with myosin family motor proteins such as non-muscle 
myosin II158. Due to its intricate actomyosin contractile machinery, actin CSK can generate 
mechanical forces that pull on the associated FA proteins as well as the ECM linked to the 
integrins158. Such mechanical contractile force, in feedback, will dictate the dynamics of integrin 
recruitment and FA assembly/disassembly158-161. This ECM-integrin-actin CSK mechanical 
linkage constitutes a main mechanism that allows the cell to "sense" the rigidity of the ECM143 
(Figure 5-1). Because of its compositional and structural complexity, FAs can potentially relay 
its force-sensitive dynamics to elicit down-stream mechanotransductive signaling via two major 
paradigms. 
 An important signaling axis downstream of integrin-mediated FA is the FAK-Src 
pathway155,162,163 (Figure 5-1), which is dominated by kinase-driven phosphorylation. Activated 
by integrin ligation, FAK is recruited to FA by binding integrin, which in turn activates FAK 
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through autophosphorylation on Y397. Further phosphorylation of FAK is completed by binding 
of FAK to Src family proteins. Together, FAK and Src form a signaling complex to relay signals 
from integrin to control downstream signaling such as the MAPK pathways including the 
FAK/Ras/Raf/MEK/ERK signaling, Fyn/Shc/Grb2/SOS/Ras signaling, p38 MAPK signaling, 
and JNK  signaling164-168, as well as the nuclear factor κB (NF-κB) signaling (Figure 5-1). 
Previous studies have demonstrated that mechanical tension as well as rigid substrate can 
activate the FAK-MAPK signaling axis169,170. The activation of MAPK pathways could further 
increase or decrease transcriptional activities of a myriad of factors. For example, the Ras/ERK 
signaling has been demonstrated as an inhibitory signal for transcription factor c-MAF171 (Figure 
5-1). Interesting, our RNA-seq analysis results indicates that MAF, the gene that encodes the 
transcription factor c-MAF, is up-regulated in hPSC-amnion cultured on soft gel bed. This 
observation appears to be consistent with the hypothesized low FAK-ERK  signaling and thereby 
high c-MAF signaling on soft substrate in hPSC-amnion. Nevertheless, a deeper study on the 
role of mechanosensitive integrin-FAK-MAPK signaling pathway on hPSC-amnion development 
is needed in the future.  
 Another important signaling axis downstream of integrin and FA is through regulating the 
actin CSK (Figure 5-1). As an intracellular structure physically anchored to FA and also an 
effector downstream of substrate rigidity and cell shape/area, the actin CSK and its integrity may 
serve as an integrator of a multitude of extracellular mechanical signals172. Supporting this view, 
recent reports have demonstrated disorganized F-actin CSK and compromised CSK contractility 
in adherent cells cultured on soft substrates173 or under high geometric confinement174. Herein I 
briefly discuss the current understanding of the role of the actin CSK in mechanotransduction. 
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Recently, the Hippo-YAP/TAZ pathway, which is important for organ size control and 
cancer175,176, has been identified as a downstream effector of the quality, dynamics as well as the 
intrinsic contractility of the F-actin CSK174,177-182 (Figure 5-1).  Interestingly, experimental 
evidence that has been accumulated in past years implicates an emerging pattern of mechanical 
regulation of the Hippo-YAP/TAZ pathway: extracellular mechanical cues (e.g., rigid substrate, 
external stretch, large cell size) resulting in prominent F-actin CSK formation can promote a 
high nuclear YAP/TAZ activity, while those cues (e.g., soft substrate and small cell size) that 
compromise the integrity of F-actin CSK lead to a low YAP/TAZ activity177,178. Specifically, by 
forming prominent F-actin CSK on rigid substrate, it substantiates YAP/TAZ signaling by 
secluding YAP/TAZ inhibitory regulators Lats1/2 and Angiomotin (Amot) to F-actin, thereby 
preventing the association between YAP/TAZ and their inhibitor proteins (Figure 5-1). Such a 
role of the F-actin CSK as a potent mechanical signal integrator has been supported by recent 
studies in both 2D and 3D contexts on a myriad of cellular behaviors and functions178. 
Furthermore, signaling through the F-actin CSK to suppress YAP activity has also been shown 
involved in regulating mechanosensitive motor neuronal differentiation of hESCs183.  
 In addition, the integrity and polymerization of actin CSK have also been implicated in 
regulating SRF (serum response factor) signaling184,185 (Figure 5-1).  Specifically, enhanced 
polymerization of cytoplasmic actin monomers (G-actin) releases MAL, a transcription co-factor, 
from its association with G-actin, resulting in MAL nuclear translocation and thus elevated SRF 
signaling.  Following this mechanism, large cell area with elevated cytoplasmic G-actin level has 
been found to inhibit SRF signaling and differentiation of epidermal stem cells184. Taken 
together, the F-actin CSK has been well-established as a mechano-sensor and integrator during 
cellular mechanotransduction.  
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 Despite that it is still unclear whether YAP/TAZ or SRF/MAL signaling is related to 
amniogenic fate specification, given the prevalence of matrix rigidity and cell spreading area in 
regulating hPSC amniogenesis, as well as the generally observed connection between actin CSK 
integrity and matrix rigidity or cell spreading, it is worthy of studying in the future whether the 
F-actin CSK could be a key signaling component of the integrative amniogenic 
mechanotransduction.  
 Moreover, since the work in this dissertation has highlighted the necessity and prominence 
of BMP-SMAD signaling in hPSC-amnion development, I am interested in examining possible 
mechanistic connections between integrin-mediated cell-ECM adhesions and BMP-SMAD 
signaling regulation during the mechano-sensitive amniogenic differentiation (Figure 5-1). In an 
interesting recent study, Zhou et al. demonstrated in endothelial cells that αVβ3 integrins can 
physically associate with BMP receptor IB (BMPRIB) under oscillatory shear flow 
stimulation186. This study further demonstrated that such integrin-BMPRIB association results in 
non-canonical SMAD1/5 activation through FAK-ERK pathway-mediated phosphorylation. As 
shown in Figure 5-1, since this non-canonical integrin-BMPR-SMAD1/5 activation paradigm is 
directly related to a critical amniogenic signaling pathway and does not seem require externally 
supplied BMP ligands,, which is consistent with our observations in this dissertation, I am 
interested in examining the possibility of this signaling pathway in the context of hPSC 
amniogenesis in the future. As a starter, anti-integrin αV or anti-integrin β3 antibodies can be used 
to treat hPSCs cultured under the Gel-3D condition, in order to assess whether αVβ3 integrins are 
required for hPSC-amnion development. In another interesting study on hMSCs, Du et al. found 
that soft substrate could promote caveolae-mediated endocytosis of β1 integrin along with the 
BMPRIA that is associated with it187 (Figure 5-1). This finding identified a mechano-sensitive 
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regulatory mechanism for controlling the amount of BMPR on cell surface, thereby adding 
another level of complexity to integrin-mediated regulation of BMP signaling. However, this 
study implies a decreased level of cell-surface BMPR and thus a lower level of BMP signaling 
on soft substrate, which is not consistent with our observation that soft matrix bed activates 
endogenous BMP signaling during hPSC amniogenesis. Taken together, the non-canonical 
integrin-BMPR-SMAD1/5 signaling axis mediated by FAK-ERK pathway seems more 
promising and will be the top candidate hypothesis to be examined in the future.       
5.2.4 Physiology and Regenerative Functions of hPSC-Amnion 
 hPSC-amnion also provides an opportunity to study and apply human amnion physiology in 
the future. For example, for over a century, human amnion has been used as a substitute for skin 
graft for facilitating wound healing in various contexts62,188-191. Such a beneficial effect has been 
largely attributed to the anti-inflammatory physiological function of amnion. Therefore, it will be 
of interest to examine whether hPSC-amnion has a similar anti-inflammatory function and if it 
has a potent capacity for stimulating wound-healing and promoting epithelial tissue regeneration 
in clinically relevant context. If effective, given the scalability of its derivation, hPSC-amnion 
might provide a substitute bioactive material to replace the cryopreserved human amnion tissues 
currently used in clinics for treating chronic non-healing wounds in patient suffered from such as 
diabetic ulcers.         
5.2.5 Morphogenic Patterning in Early Human Amniotic Sac Development 
 In this dissertation, we demonstrated a novel in vitro model, the ASE, for early human 
amniotic sac development. However, the ASE-derivation efficiency using the current culture 
system is low, probably because of its high-efficiency in inducing amniogenic differentiation. 
Indeed, I observed in previous experiments that some asymmetric cysts appearing at earlier days 
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(e.g., day 3) eventually completely differentiated to squamous cysts at later days (e.g., day 5), 
suggesting strong pro-amniogenesis property of the current culture system. Therefore, to 
promote the application of the in vitro amniotic sac model in fundamental and translational 
studies, it will be of great importance to develop a more efficient system for inducing the 
asymmetric cysts, or ASEs.  
 Since now that BMP signaling is shown to be involved in the development of amnion, one 
might develop an efficient ASE induction system by engineering asymmetric induction of BMP  
signaling (Figure 5-2). For example, one might culture hPSCs first under an anti-amniogenic 
condition, e.g., Gel-2D, and then apply asymmetric amniogenic induction by treating cells with 
BMP only at one side (Figure 5-2). Such an asymmetric induction system can be achieved, in 
principle, by leveraging microfluidic gradient-generating devices192. Furthermore, it is also 
possible to apply additional inductive signals for gastrulation only to the columnar side of the 
cyst (Figure 5-2) once the squamous amnion takes its form. By doing so, we could potentially 
 
Figure 5-2 Schematic showing the concept of a defined ASE induction system. In this 
system, exogenous differentiating factors are added in an asymmetric manner to cultured hPSC 
clusters/cysts in vitro. Specifically, BMP ligand is provided to one side of the cyst at 
decreasing concentration over the time course to induce the development of the squamous, 
amnion-like tissue (red); in the meantime, growth factors known to be involved in primitive 
streak development, such as TGFβ, BMP4, and WNT, are introduced to the 
columnar/embryonic disc (blue) side of the cyst at increasing concentration over the time 
course to induce the development of gastrulating cells (cyan).   
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achieve modeling early human embryonic development at both implantation and gastrulation in a 
defined and controlled manner in vitro.  
  The ASE reported in this dissertation provides an important tool for studying the 
morphogenesis, especially the bipolar amnion-epiblast patterning, during human amniotic sac 
development. It will be of significant interest to study the cellular and molecular mechanisms 
underlying such patterning - at both cellular and tissue scale - in the future to deepen our 
understanding of human amniotic sac development. For example, the cellular process via which 
early epiblast cells organize and form the amniotic cavity (the lumen) remains unknown and can 
be studied using the ASE system with the help of high-resolution live-cell imaging and hPSCs 
that have forced expression of fluorescently tagged apical proteins like EZRIN or PODXL. The 
mechanism underlying the formation of a tissue boundary between the squamous amnion and the 
columnar epiblast is also an intriguing yet still mysterious question, which can be studied in 
future by leveraging the ASE system. In particular, the cell-cell cross-talk between 
amnion/epiblast at the site where the boundary forms would be interesting to investigate. The 
spontaneous patterning of BMP-SMAD signaling in ASEs, which implies the existence of a 
BMP signaling gradient - also merits deeper studies in the future; this goal could be achieved 
using hPSCs expressing and secreting fluorescently tagged functional BMP4 proteins. In 
addition, the emergence of PS-like development from the ASE is another interesting observation 
of self-patterning phenomenon in this dissertation. However, the mechanism for the spontaneous 
initiation and subsequent ingression/egression of PS-like cells in the ASE remains to be studied 
in future. For example, by leveraging the CRISPR/CAS9 genome editing tool, we can potentially 
screen a variety of EMT-TFs, e.g., SNAIL, SLUG, TWIST1/2, ZEB1, for their role in either the 
initiation of PS or the subsequent dissemination of gastrulating cells.  
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5.2.6 Micro-engineered High-Throughput Screening System for Reproductive Medicine  
 In this dissertation, we demonstrated the proof of concept for a micro-engineered platform 
containing hPSC-derived amnion-like tissue arrays. However, the application of this system 
remains to be demonstrated in future. Specifically, experiments need to be conducted to test the 
compatibility of such a micro-tissue array system with high-throughput screening process. In 
addition, it will be of interest to apply this system to screen the effect of a library of drugs or 
small molecule inhibitors on the development of hPSC-amnion. It is also of importance to use 
this system to test the toxicity of various environmental toxicants, such as lead and mercury, as 
well as other public health hazards, to early amnion development. It is also possible to use this 
system as a supplementary test to predict the reproductive success in clinics if using hiPSCs 
derived from patients with reproductive health concerns.    
 In all, it is envisioned that the findings reported in this dissertation will lead to new trends at 
both the fundamental and the clinical fronts of scientific research in bioengineering, biomaterial 






























APPENDIX A. General Cell Biology Assays 
Cell lines  
 This dissertation used hPSC lines that included H9 (WA09, P50, WiCell; NIH registration 
number: 0062), H7 (WA07, P52, WiCell; NIH registration number: 0061), UM63-1 (P25, 
provided by Dr. Gary D. Smith at the University of Michigan MStem Cell Laboratories; NIH 
registration number: 0277), and 1196a (an iPSC line, P42, from the University of Michigan 
Pluripotent Stem Cell Core1). All protocols for the use of hPSC lines were approved by the 
Human Pluripotent Stem Cell Research Oversight Committee at the University of Michigan. All 
hPSC lines have been authenticated by the original sources and also authenticated in-house by 
immunostaining for pluripotency markers and successful differentiation to three germ layer cells. 
All hPSC lines were maintained in a feeder-free system for at least 10 passages and authenticated 
as karyotypically normal at the indicated passage number. Karyotype analysis was performed by 
Cell Line Genetics (Madison, USA). All hPSC lines were tested negative for mycoplasma 
contamination (LookOut Mycoplasma PCR Detection Kit, Sigma-Aldrich). 
 
Cell culture  
 hPSCs were maintained in a standard feeder-free culture system using mTeSR1 medium 
(STEMCELL Technologies) and lactate dehydrogenase-elevating virus (LDEV)-free hESC-
qualified reduced growth factor basement membrane matrix GeltrexTM (Thermo Fisher 
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Scientific; derived from Engelbreth-Holm-Swarm tumors similarly as Matrigel®) per the 
manufacturers' instructions. All cultures were visually examined during every passage to ensure 
the absence of spontaneously differentiated, mesenchymal-like cells in the culture. All hPSCs 
were used before reaching P70. 
 
Cell fixation and immunocytochemistry (also known as immunofluorescence analysis) 
 hPSCs were fixed in 4% paraformaldehyde (buffered in 1 × PBS) for 30 min, and 
permeabilized in 0.1% SDS (sodium dodecyl sulfate, dissolved in PBS) solution for another 30 
min. Samples were first incubated in 2% goat serum solution (Thermo Fisher Scientific) at 4°C 
for 24 h, and then with primary antibody solution prepared in 2% goat serum at 4°C for another 
24 h. Samples were then labeled with goat-raised secondary antibodies (1:500) at 4°C for 24 h. 
HOECHST 33342 (Thermo Fisher Scientific) was used for counterstaining the cell nucleus. 
Alexa-fluor dye-conjugated wheat germ agglutinin (WGA; Thermo Fisher Scientific) was used 
as a pan-cell membrane marker. All primary antibodies, their sources, and dilutions are listed in 
Table B-1. 
 
Confocal microscopy and image analysis 
 Images were acquired on an Olympus 1X81 fluorescence microscope equipped with a CSU-
X1 spinning-disc unit (YOKOGAWA) or a Nikon-A1 laser scanning confocal microscope 
(Nikon). Fluorescence images acquired from confocal microscopy were reconstructed in 3D 
using Imaris8.2 (Bitplane). 
 
Cell and cyst morphology characterization 
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 Measurements of cell nucleus dimensions, cyst epithelial thickness, and cell cluster size 
were performed manually using the Measurement tool in ImageJ (NIH)11. The normalized 
nucleus dimension, defined as the ratio of nucleus dimension along the apico-basal direction to 
that along the lateral direction, was then calculated. Distance between the apical and basal 
surfaces (both stained by WGA) of the epithelium was measured at 5 different positions evenly 
distributed along the circumference of the cyst. The average of these 5 measurements was used 
as the representative epithelial thickness for a cyst. 
  
Western blotting  
 Whole cell lysates were prepared from cells and homogenized by sonication. Proteins in 
lysates were separated via SDS-polyacrylamide gel electrophoresis (SDS-PAGE) before 
transferring to PVDF membranes. PVDF membranes were then incubated with blocking buffer 
(Li-Cor) for 1 h and then with primary antibodies (Table B-1) at 4°C overnight with gentle 
shaking. Blots were then incubated with IRDye secondary antibodies (Li-Cor) for 1 h before 
imaging using the Li-Cor Odyssey Sa Infrared Imaging System (Li-Cor). The investigator who 
performed the Western blotting was blinded to the test condition allocation during the 
experiment.  
 
Total RNA isolation 
 Samples were collected and prepared for RNA isolation following a protocol commonly 
used for processing in vivo tissues. In brief, samples were washed with DMEM/F12 to remove 
ECM overlay. Cysts (ca. 5,000 or more per sample) were then scraped from the culture substrate, 
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before being spun down at 1,000 rpm for 3 min in a conical tube. RNA was isolated from the cell 
pellet using an RNeasy Micro Kit (QIAGEN) following the manufacturer's instruction. 
 The total RNA from fetal human amniotic epithelial cells was provided by Dr. Toshio Miki 
(University of South California). The RNA isolation was conducted by following the protocol 
below. Fetal placentae were obtained from the Allegheny Reproductive Health Center under the 
approval of the University of Pittsburgh’s Internal Review Board and prior written consents of 
the donors193. Any patient tested positive for human immunodeficiency virus, hepatitis B virus, 
hepatitis C virus, tuberculosis, chlamydia trachomatis, neisseria gonorrhoeae, syphilis or any 
placenta showing macroscopic abnormality were excluded. Human amniotic epithelial (AE) cells 
were enzymatically isolated from the amniotic membrane as previously described194. In brief, the 
amnion layer was mechanically separated from the chorion layer and washed several times with 
phosphate buffered saline (PBS) without calcium and magnesium to remove blood. To dissociate 
AE cells, the amniotic membrane was incubated at 37°C with 0.05% trypsin containing 0.53mM 
EDTA-4Na (Life Technologies). Digest from the first 10 min of trypsin digestion was discarded 
to exclude debris. Cells from the second and third 40 min digests were pooled and washed three 
times with PBS and immediately cryopreserved with embryonic stem cell-qualified fetal bovine 
serum containing 10% DMSO. Total RNA was isolated from the cryopreserved samples by using 
Trizol and DNA-Free RNA Kit (Zymo Research). 
 
Quantitative reverse transcription polymerase chain reaction (qRT-PCR) analysis 
 RNA quality and quantity were determined using a NanoDrop 1000 spectrophotometer 
(Thermo Scientific). Reverse transcription was performed using the iScriptTM cDNA synthesis 
Kit (Bio-Rad). qRT-PCR analysis was performed using Quantitect Sybr Green MasterMix 
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(QIAGEN) and specific primers (as listed in Table C-1) on a CFX ConnectTM Real-Time System 
(Bio-Rad). qRT-PCR result was considered as "not detected" when no signal was observed 
within 40 cycles. Human GAPDH was used as an internal control for quantifying relative gene 
expression by using the 2−∆Ct method195. All analyses were performed with 2 - 3 technical 
replicates and ≥ 3 biological replicates as described in figure captions.  
 
RNA-sequencing and data analysis  
 mRNA-sequencing was performed by the University of Michigan DNA Sequencing Core 
following Illumina guideline. RNA samples were sequenced on an Illumina HiSeq-2500 High-
Output system generating 50 cycle single reads. Samples were barcoded and run on a single lane. 
Publically available RNA-seq data (GSE66302) were downloaded from GEO. Reads were 
mapped to the human reference genome (Build hg19) using STAR196 and tabulated using 
HTSeq197. Differential RNA expression was determined using edgeR198. Normalized levels of 
gene expression and the color scale were determined by scaling raw reads for each gene to 
account for different total read counts across samples before values were log2 transformed. Raw 
and processed RNA-seq data files used in this dissertation have been deposited in Gene 
Expression Omnibus (GEO, accession number GSE89479). 
 
Cluster analysis  
 Hierarchical clustering analysis of transcript expression data was performed within Cluster 
3.0 using uncentered correlation with average linkage199. Java Treeview was used for visualizing 
the clustered data200. 
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Gene ontology (GO) enrichment analysis  
 Quality check of the data was conducted using the Trinity toolkit 
(https://github.com/trinityrnaseq/trinityrnaseq/wiki/QC-Samples-and-Replicates)201. Differential 
expression analysis was carried out for hPSC-amnion, 9-week human amnion, human chorion, 
and human placenta, respectively, relative to hPSCs, with the DESeq2 package 
(https://www.bioconductor.org/packages/release/bioc/html/DESeq2.html)202. The output 
(.DE_results) were converted to an Excel format, sorted by log2 fold change and used as a 
unified set for GO enrichment analysis by DAVID, v6.8 (https://david.ncifcrf.gov). 
 
Gene set enrichment analysis (GSEA)  
 Genes were ranked by fold change in expression level relative to hPSCs. The entire ranked 
data set (i.e., genes enriched and depleted in amnion-like cysts) was queried for 35 genes of the 
ALK-pathway-related gene set, BIOCARTA_ALK_PATHWAY, using the GSEA software 





APPENDIX B. List of Primary Antibodies 
Table B-1 List of primary antibodies used for the immunocytochemistry (ICC) and western 
blotting (WB). 
Protein Species Application Catalog No. Vendor 
EZRIN Mouse 1:2000 (ICC) E8897 Sigma-Aldrich 
E-CADHERIN Mouse 1:500 (ICC) 1:1000 (WB) 610181 BD Biosciences 
NANOG Rabbit 1:500 (ICC) 1:2000 (WB) 4903S Cell Signaling Technology 
OCT4 Mouse 1:200 (ICC) 1:500 (WB) SC-5279 Santa-Cruz Biotechnology 
SOX2 Rabbit 1:1000 (ICC) 1:1000 (WB) 09-0024 Stemgent 
GAPDH Rabbit 1:1000 (WB) SC-25778 Santa-Cruz Biotechnology 
BRACHYURY Rabbit 1:100 (ICC) SC-20109 Santa-Cruz Biotechnology 
SNAIL Rabbit 1:100 (ICC) SC-28199 Santa-Cruz Biotechnology 
SLUG Rabbit 1:400 (ICC) 9585 Cell Signaling Technology 
N-CADHERIN Rat 1:500 (ICC) MNCD2-c Developmental Studies Hybridoma Bank 
FOXA2 Rabbit 1:500 (ICC) WRAB-1200 Seven Hills Bioreagents 
pSMAD1/5 Rabbit 1:100 (ICC) 1:1000 (WB) 9516S Cell Signaling Technology 
SMAD1/5/8 Rabbit 1:1000 (WB) SC-6031-R Santa-Cruz Biotechnology 
CDX2 Mouse 1:500 (ICC) CDX2-88 Biogenex 
GATA3 Mouse 1:100 (ICC) SC-268 Santa-Cruz Biotechnology 
SSEA-4 Mouse 1:500 (ICC) MAB4304 EMD Millipore 
BMP4 Mouse 1:1000 (WB) 4680 Cell Signaling Technology 
E-CADHERIN Rabbit 1:100 (ICC) ab15148 Abcam 
β-CATENIN Mouse 1:200 (ICC) 610153 BD Biosciences 
OCT4 Rabbit 1:500 (ICC) 2750 Cell Signaling Technology 
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APPENDIX C. List of qRT-PCR Primers 
Table C-1 List of primers used for the qRT-PCR analysis.  
Gene Primer Sequences (5' -> 3') Reference 
NANOG Forward: GATTTGTGGGCCTGAAGAAA NA 
  Reverse: ATGGAGGAGGGAAGAGGAGA NA 
OCT4 Forward: GTGGAGGAAGCTGACAACAA NA 
  Reverse: GGTTCTCGATACTGGTTCGC NA 
SOX2 Forward: GCTTAGCCTCGTCGATGAAC NA 
  Reverse: AACCCCAAGATGCACAACTC NA 
GAPDH Forward: CTCTGCTCCTCCTGTTCGAC NA 
  Reverse: TTAAAAGCAGCCCTGGTGAC NA 
CDH1 Forward: TCTTCAATCCCACCACGTACA NA 
  Reverse: TGCCATCGTTGTTCACTGGA NA 
CDH2 Forward: ATCAACCCCATACACCAGCC NA 
  Reverse: GTCGATTGGTTTGACCACGG NA 
CLDN6 Forward: TGTTCGGCTTGCTGGTCTAC PrimerBank204 
  Reverse: CGGGGATTAGCGTCAGGAC PrimerBank 
BRACHYURY Forward: TGCTGCAATCCCATGACA PrimerBank 
  Reverse: CGTTGCTCACAGACCACA PrimerBank 
SNAI1 Forward: TCGGAAGCCTAACTACAGCGA PrimerBank 
  Reverse: AGATGAGCATTGGCAGCGAG PrimerBank 
SNAI2 Forward: CGAACTGGACACACATACAGTG PrimerBank 
  Reverse: CTGAGGATCTCTGGTTGTGGT PrimerBank 
FOXA2 Forward: CGACTGGAGCAGCTACTATGC NA 
  Reverse: TACGTGTTCATGCCGTTCAT NA 
GATA2 Forward: CAGCAAGGCTCGTTCCTGTT PrimerBank 
  Reverse: GGCTTGATGAGTGGTCGGT PrimerBank 
GATA3 Forward: GCCCCTCATTAAGCCCAAG PrimerBank 
  Reverse: TTGTGGTGGTCTGACAGTTCG PrimerBank 
CDX2 Forward: GACGTGAGCATGTACCCTAGC PrimerBank 
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  Reverse: GCGTAGCCATTCCAGTCCT PrimerBank 
TP63 Forward: CTGGAAAACAATGCCCAGA Li et al.78 
  Reverse: AGAGAGCATCGAAGGTGGAG Li et al.78 
GATA4 Forward: CGACACCCCAATCTCGATATG PrimerBank 
  Reverse: GTTGCACAGATAGTGACCCGT PrimerBank 
GATA6 Forward: CTCAGTTCCTACGCTTCGCAT PrimerBank 
  Reverse: GTCGAGGTCAGTGAACAGCA PrimerBank 
KRT7 Forward: AGGATGTGGATGCTGCCTAC Li et al.78 
  Reverse: CACCACAGATGTGTCGGAGA Li et al.78 
CGA Forward: CACTCCACTAAGGTCCAAGAAGA PrimerBank 
  Reverse: CCGTGTGGTTCTCCACTTTGA PrimerBank 
HLA-G Forward: GAGGAGACACGGAACACCAAG PrimerBank 
  Reverse: GTCGCAGCCAATCATCCACT PrimerBank 
ITGB6 Forward: CTCAACACAATAAAGGAGCTGGG PrimerBank 
  Reverse: AAAGGGGATACAGGTTTTTCCAC PrimerBank 
VTCN1 Forward: TCTGGGCATCCCAAGTTGAC PrimerBank 
  Reverse: TCCGCCTTTTGATCTCCGATT PrimerBank 
GABRP Forward: TTTCTCAGGCCCAATTTTGGT PrimerBank 
  Reverse: GCTGTCGGAGGTATATGGTGG PrimerBank 
MUC16 Forward: GGAGCACACGCTAGTTCAGAA PrimerBank 
  Reverse: GGTCTCTATTGAGGGGAAGGT PrimerBank 
HAND1 Forward: CCAAGGATGCACAGTCTGG PrimerBank 
  Reverse: AGGAGGAAAACCTTCGTGCTG PrimerBank 
POSTN Forward: GAAAGGGAGTAAGCAAGGGAG Dobreva et al.83 
  Reverse: ATAATGTCCAGTCTCCAGGTTG Dobreva et al.83 
TFAP2A Forward: GCATATCCGTTCACGCCGAT Tadeu et al.205 
  Reverse: GGGAGATTGACCTACAGTGCC Tadeu et al.205 
TFAP2B Forward: AGCAAATGTCACGTTACTCACC PrimerBank 
  Reverse: TGTGCTGCCGGTTCAAATACT  PrimerBank 
KRT17 Forward: AAGATCCGTGACTGGTACCAGAGG Sankar et al.206 
  Reverse: GATGTCGGCCTCCACACTCAGG Sankar et al.206 
KRT18 Forward: TCGCAAATACTGTGGACAATGC PrimerBank 
  Reverse: GCAGTCGTGTGATATTGGTGT PrimerBank 
BMP2 Forward: ACTACCAGAAACGAGTGGGAA PrimerBank 
  Reverse: GCATCTGTTCTCGGAAAACCT PrimerBank 
BMP4 Forward: TCCACAGCACTGGTCTTGAG Xu et al.207 
  Reverse: GGGATGTTCTCCAGATGTTCTT  Xu et al.207 
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BMP6 Forward: AGCGACACCACAAAGAGTTCA PrimerBank 
  Reverse: GCTGATGCTCCTGTAAGACTTGA PrimerBank 
BMP7 Forward: TCGGCACCCATGTTCATGC PrimerBank 
  Reverse: GAGGAAATGGCTATCTTGCAGG PrimerBank 
  
NA: not applicable. 
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APPENDIX D. List of 108 putative pluripotency genes 
Table D-1 List of 108 putative pluripotency genes detected in hPSCs and hPSC-amnion in 
RNA-seq. Genes86 are consecutively listed as plotted, from left to right, in Figure 2-17.  
1 CUZD1 28 SCLY 55 TOMM40 82 RLIM 
2 CER1 29 TXLNG 56 SEPHS1 83 RC3H2 
3 CCL26 30 JMJD1C 57 SLIRP 84 PINX1 
4 LEFTY2 31 EIF2AK4 58 EMG1 85 RPRM 
5 GDF3 32 TARS 59 DDX18 86 GRPR 
6 ADD2 33 SNURF 60 MTAP 87 GNPTAB 
7 DDX21 34 RRP15 61 TFAM 88 FGF2 
8 PNO1 35 USP45 62 NIP7 89 MYO1E 
9 DPPA4 36 SHISA9 63 HSPD1 90 LARP7 
10 RRAS2 37 NANOG 64 TIMM8A 91 CACHD1 
11 GABRB3 38 CCRN4L 65 POU5F1 92 PHC1 
12 RPL22L1 39 C10orf76 66 POU5F1P3 93 VRTN 
13 MDN1 40 EXOC2 67 DDX6 94 TERF1 
14 GAL 41 G3BP2 68 CENPN 95 CHAC2 
15 PMAIP1 42 PHAX 69 TUBB2B 96 TDGF1 
16 BICD1 43 CDC25A 70 DENR 97 SLC25A21
17 AKIRIN1 44 MTHFD1L 71 CASP3 98 USP44 
18 FGD6 45 RNASEH1 72 SKP2 99 LEFTY1 
19 MRS2 46 L1TD1 73 MKKS 100 NODAL 
20 BPTF 47 LRR1 74 NUDT15 101 RRM2 
21 KIF13A 48 MRPS30 75 FKBP4 102 GLB1L3 
22 RAC3 49 PSME3 76 NUP160 103 C21orf88 
23 C9orf85 50 MSH2 77 TMPO 104 SMPDL3B
24 DNAH14 51 EEF1E1 78 MMS22L 105 UNC5D 
25 METTL21A 52 NLN 79 ESRP1 106 LECT1 
26 METTL8 53 LOC100506054 80 SKIL 107 ZIC3 
27 BCAT1 54 NOLC1 81 SNX5 108 RTP1 
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APPENDIX E. Differentially regulated genes in hPSC-amnion 
Table E-1 List of 50 most up-regulated genes (UP-50) and 50 most down-regulated genes 
(DOWN-50) in hPSC-amnion compared with hPSCs. Genes are consecutively ranked as plotted, 
from left to right, in Figure 2-17.  
UP-50 genes DOWN-50 genes 
Rank Gene Rank Gene Rank Gene Rank Gene 
1 HAND1 26 PLSCR5 1 CUZD1 26 VTN 
2 TFAP2B 27 HOXC13 2 CH25H 27 IFITM5 
3 ISL1 28 MEIS1 3 PTGFR 28 MIRLET7BHG 
4 LUM 29 WNT6 4 TMPRSS3 29 LOC399829 
5 C8orf4 30 NR2F2 5 JAKMIP2-AS1 30 XIST 
6 EVX1 31 MSX2 6 ANKRD22 31 KCNJ1 
7 DLX5 32 CCR1 7 ISL2 32 UCP1 
8 TBX3 33 CYSLTR2 8 RXFP1 33 TNFAIP6 
9 HOXB2 34 EPAS1 9 PCDHB1 34 C3orf72 
10 ERP27 35 KRT23 10 OLIG3 35 SEZ6 
11 COL3A1 36 TP63 11 WDR49 36 CBLN4 
12 GATA3 37 MEIS1-AS3 12 AQP7 37 LOC100127888
13 GUCY1A3 38 BARX2 13 NLRP10 38 FREM3 
14 P2RY6 39 HMX1 14 NPTX1 39 TMEM114 
15 TNFSF8 40 HOXC6 15 LOC100507387 40 DRD1 
16 TFAP2A 41 HOXB-AS1 16 TAC1 41 DSG3 
17 DCN 42 IGFBP7 17 GABRA1 42 PRSS56 
18 VGLL1 43 DIO3 18 FOXE1 43 CCR9 
19 HOXB9 44 HOXB3 19 NXF4 44 GPR17 
20 GATA3-AS1 45 LOC642366 20 TPH2 45 PAPLN 
21 CDX2 46 ITGA8 21 RUFY4 46 COL20A1 
22 PGLYRP4 47 C1orf105 22 HTR1A 47 HMX2 
23 SLC40A1 48 ANKRD1 23 SERPINB4 48 LOC100507244
24 CHI3L2 49 LCP1 24 NEUROG3 49 TPSB2 
25 HAND2 50 DLX6 25 CDH19 50 MPO 
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APPENDIX F. Tabulated Gene Set Enrichment Analysis Results 
Table F-1 Tabulated gene set enrichment analysis results. The data set (hPSC-amnion versus 
hPSCs) was queried using the gene set, BIOCARTA_ALK_PATHWAY, a collection of 35 
genes related to BMP signaling.  
Gene set BIOCARTA_ALK_PATHWAY 
Enrichment score (ES) 0.7473358 
Normalized enrichment 
score (NES) 2.1402795    
Nominal p-
value  0    
FDR q-value 0 












1 BMP4 BMP4 123 6.028 0.1195 Yes 
2 NOG NOG 224 4.789 0.2144 Yes 
3 TGFB2 TGFB2 328 3.962 0.2919 Yes 
4 SMAD6 SMAD6 348 3.879 0.3714 Yes 
5 BMP5 BMP5 434 3.509 0.4404 Yes 
6 FZD1 FZD1 618 2.794 0.4904 Yes 
7 NKX2-5 NKX2-5 754 2.632 0.5391 Yes 
8 NPPB NPPB 1070 1.929 0.5654 Yes 
9 BMP10 BMP10 1088 1.924 0.6045 Yes 
10 BMP2 BMP2 1517 1.479 0.6166 Yes 
11 NPPA NPPA 1598 1.408 0.6424 Yes 
12 TGFB1 TGFB1 1638 1.381 0.6693 Yes 
13 GATA4 GATA4 1660 1.356 0.6964 Yes 
14 CHRD CHRD 1747 1.294 0.7195 Yes 
15 BMPR2 BMPR2 2175 1.04 0.7226 Yes 
16 BMP7 BMP7 2468 0.935 0.7294 Yes 
17 GSK3B GSK3B 2661 0.885 0.7394 Yes 
18 CTNNB1 CTNNB1 2873 0.824 0.7473 Yes 
19 SMAD1 SMAD1 4004 0.62 0.7114 No 
20 BMPR1A BMPR1A 4196 0.593 0.7154 No 
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21 SMAD5 SMAD5 5296 0.452 0.6773 No 
22 MEF2C MEF2C 5496 0.428 0.6776 No 
23 MAP3K7 MAP3K7 6985 0.268 0.6188 No 
24 HNF1A 7505 0.217 0.6009 No 
25 ATF2 ATF2 9280 0.063 0.5256 No 
26 SMAD4 SMAD4 9814 0.005 0.5027 No 
27 RFC1 RFC1 12640 -0.02 0.3811 No 
28 ACVR1 ACVR1 13433 -0.105 0.349 No 
29 TGFBR2 TGFBR2 13945 -0.164 0.3304 No 
30 AXIN1 AXIN1 14035 -0.175 0.3301 No 
31 DVL1 DVL1 14975 -0.301 0.2958 No 
32 TGFB3 TGFB3 15146 -0.327 0.2953 No 
33 APC APC 15186 -0.333 0.3005 No 
34 TGFBR1 TGFBR1 15434 -0.371 0.2975 No 
35 MYL2 MYL2 20846 -1.802 0.1011 No 
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